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1.1 T lymphocytes 
1.1.1 The immune system 
Pathogenic microorganisms such as bacteria, viruses, fungi, protozoan- and multicellular 
parasites pose a constant threat to higher developed organisms. They can invade the body 
through different routes with most pathogens entering via mucosal surfaces of the urogenital, 
digestive and respiratory tracts. Once an organism is successfully colonised, pathogens can 
harm the host in several ways ranging from the competition for nutrients over the production 
of poisonous metabolic products to the direct induction of cytopathic effects. This may 
damage or destroy vital tissues and organs and eventually cause death of the host. In order 
to defend the organism against pathogens but also to remove malignant host cells, a multi-
faceted array of cells and molecules has evolved which is referred to as the immune system. 
It consists of two distinct but intertwined arms which fulfil different but equally important tasks 
in providing effective resistance against various threats.  
 
The innate immune system represents the front line of host defence and has a wide variety 
of mechanisms at it disposal for combating infections. Those include physical barriers 
presented by epithelial tissues which line body surfaces, physiological barriers such as 
antibacterial peptides and the complement system as well as numerous innate immune cells 
which patrol the periphery. These cells are equipped with a set of germline encoded 
receptors, so-called pattern recognition receptors (PRR), that recognise conserved and 
ubiquitously expressed structures found on many pathogens. Using these receptors, innate 
immune cells can instantly engage invading microorganisms and frequently prevent the 
establishment of an infectious focus. The downside of innate immune responses is that they 
are neither specific for a particular pathogen nor do they lead to the development of an 
immunological memory. Once pathogens manage to overcome innate immunity and 
establish a focus of infection, different and more sophisticated mechanisms are required in 
order to protect the host.  
 
The adaptive immune system which is unique to vertebrates provides such improved 
protection by employing mechanisms of its humoral and cell-mediated branches. A hallmark 
of the adaptive immune system is its inherent flexibility which allows the recognition of 
virtually unlimited numbers of different antigens. This is achieved by employing specialised 
receptors on the surface of lymphocytes which are generated by highly diverse and variable 
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recombination events on the DNA level. The generation of sufficient amounts of lymphocytes 
that bear highly antigen-specific receptors is a rather slow process that requires interactions 
between cells of the innate and the adaptive immune system. However, this process also 
leads to the generation of long-lived memory cells which trigger stronger and more 
immediate responses upon subsequent infections with the same pathogen. While 
B lymphocytes provide humoral immunity by secreting antigen-specific antibodies into the 
body fluids, T lymphocytes or T cells are not only implicated in this process as well but they 
are also the principal mediators of cell-mediated adaptive immunity. 
 
1.1.2 Thymocyte development 
The development of T cell precursors or thymocytes is a highly ordered process that takes 
place in the thymus. Together with the bone marrow (BM), the thymus belongs to the primary 
lymphoid organs and is essential for the development of prospective T cells (van Ewijk, 1991; 
Carlyle and Zúñiga-Pflücker, 1996). It consists of numerous lobules each divided into an 
outer cortex where most stages of thymocyte development occur and an inner medulla 
region. Thymocyte development begins with the entry of common lymphoid progenitors 
(CLP) into the thymus via blood vessels located in the corticomedullary junction (Cantor & 
Weissmann 1976; Kondo et al., 1997). These cells lack expression of characteristic T cell 
surface molecules including the T cell receptor (TCR), the CD3-complex which is necessary 
for TCR-dependent signalling and the TCR co-receptors CD4 and CD8. Due to lack of the 
latter two, these cells are referred to as CD4 and CD8 double negative (DN) cells. Initial 
interaction with the thymic stroma in the subcapsular region of the cortex triggers a 
differentiation process which leads to the expression of first T cell-specific surface markers 
such as CD2. While these cells can give rise to different T cell populations including the 
minority lineages of the NKT cells and  T cells, the majority develops into the dominating 
population of  T cells (Fehling et al., 1999). DN cells can be further subdivided according 
to surface expression of the adhesion molecule CD44 and the IL-2 receptor -chain CD25 
(Godfrey et al., 1993). Cells of the DN1 stage (CD25- CD44+) have recently entered the 
thymus and their TCR-encoding genes are still in the germline configuration. These cells 
progress via the DN2 stage (CD25+ CD44+) to the DN3 stage (CD25+ CD44-) where 
rearrangement of the TCR -chain locus occurs through the process of VDJ recombination 
(Bonati et al., 1992). Upon successful rearrangement of this locus, the cells start expressing 
the pre-TCR which consists of the -chain and a surrogate -chain (von Böhmer and 
Fehling, 1997). This receptor associates with CD3 molecules and transduces signals into the 
cell leading to the arrest of further -chain rearrangement and promoting differentiation into 
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the DN4 stage (CD25- CD44-) after several rounds of proliferation. Soon after, cells migrate 
to the cortex and start with the expression of CD4 and CD8 co-receptors which defines them 
as CD4 and CD8 double positive (DP) cells. At this stage, multiple rearrangement attempts 
can be made at the  locus after which most cells succeed to produce a functional -chain 
that replaces the pre -chain thus generating a functional  TCR (Thompson et al., 1990). 
Although  TCRs are highly variable and allow the generation of immune responses to a 
wide array of pathogens, they are subject to major histocompatibility complex (MHC) 
restriction meaning that they can only recognise peptides that are presented on MHC 
molecules. This important aspect of TCR-mediated antigen recognition forms the basis of 
subsequent stages in thymocyte development which are positive selection, negative 
selection and lineage commitment. Positive selection occurs in the cortex and is mediated by 
specialised thymic epithelial cells (cTEC) which present self antigen on MHC class I and 
MHC class II molecules to DP cells (Marrack and Kappler, 1997). Only thymocytes which 
successfully recognize peptide:MHC complexes survive while those that fail die by neglect. 
In addition to positively selecting cells that recognise self antigens with a low avidity, the 
TCR-intrinsic specificity for molecules of either MHC class also determines which co-receptor 
a mature T cells will express. While TCR and CD8 engagement with MHC class I commits 
the thymocyte to develop into a CD8 single positive (SP) cell, interaction with MHC class II 
leads to a loss of CD8 expression and destines the DP thymocyte to become a CD4 SP 
T cell (von Böhmer et al., 1989). However, cells which display a high avidity for self antigens 
pose a threat to the organism and are removed in the process of negative selection (Punt et 
al., 1994). This process is mediated by BM-derived cells such as macrophages and dendritic 
cells (DC) and also by medullary thymic epithelial cells (mTEC) (Hoffmann et al., 1992). 
Eventually, naïve self-tolerant SP T cells leave the thymus via the medulla and begin to 
circulate between blood and lymphoid tissues until they encounter their specific antigen. 
 
1.1.3 T cell activation 
In order to become activated and differentiate into effector cells, naïve T cells require at least 
two separate signals for their activation (Bretscher and Cohn, 1970). The first one is 
transmitted through the TCR upon recognition of a foreign antigen. Since T cells are not able 
to recognise their specific antigen directly due to MHC restriction of the TCR, they require 
accessory cells to process and present antigens in the form of small peptides bound to MHC 
molecules. In addition to the presented antigen, T cells also depend on co-stimulatory signals 
delivered through distinct surface receptors which are essential for their proper activation. 
These tasks are performed by a specialised subset of cells which are the so-called 
professional antigen-presenting cells (APC). These include DCs which are the main 
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mediators of T cell activation but also macrophages and B cells. APCs reside as immature 
cells in peripheral non-lymphoid tissues and act as sentinels patrolling for foreign antigens. In 
this state, they are characterised by a high endocytic activity but only a weak expression of 
MHC and co-stimulatory molecules. On their surface, APCs bear an array of conserved 
receptors such as Toll-like receptors (TLR) and C-type lectin receptors (CLR) that are able to 
recognise pathogen-associated molecular patterns (PAMP). Recognition of pathogens leads 
to their ingestion by receptor-mediated endocytosis which has several consequences. Firstly, 
the engulfed pathogen is degraded and its peptides are presented on MHC molecules whose 
expressions are drastically upregulated. Secondly, the APCs become activated and begin to 
express high levels of cell-adhesion and co-stimulatory molecules such as those of the B7 
family which are pivotal for T cell activation (Greenwald et al., 2005). Thirdly, activated APCs 
rapidly loose their ability for endocytosis and migrate to draining lymphoid tissues where they 
act as potent initiators and modulators an adaptive immune responses (Steinmann et al., 
1997). 
 
Naïve T cells that circulate through the periphery enter secondary lymphoid organs via high 
endothelial venules trough a process which requires interaction of adhesion molecules on 
T cells and endothelial cells. Upon entry into lymphoid organs, T cells begin to sample 
MHC:peptide complexes presented on APCs until they recognise a complex with high avidity 
on activated cells. This induces conformational changes in T cell adhesion molecules that 
stabilises the T cell-APC interaction (Lebedeva et al., 2005). In addition, T cells receive 
activation signals both through the TCR and through several co-stimulatory receptors which 
belong to the immunoglobulin- and tumour necrosis factor receptor (TNFR) superfamilies. 
These include activating receptors such as CD28, CD40L and the inducible T cell co-
stimulator (ICOS) whose ligands are expressed on activated APCs but also negative 
regulators like cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1) 
and B- and T-lymphocyte attenuator (BTLA) which compete for ligand binding thus limiting T 
cell activation (Rudd and Schneider 2003; Watanabe et al., 2003). Supply of co-stimulatory 
signals is essential for T cell activation as antigen recognition in their absence can cause 
apoptosis or lead to anergy (Kroczek et al., 2004). In contrast, the availability of both signals 
triggers the proliferation and differentiation of naïve T cells into effector T cells, a process 
which is largely driven by the cytokine Interleukin (IL)-2 and accompanied by the expression 
of activation markers such as CD69 and CD25 (Parry et al., 2003; Caruso et al., 1997). 
Importantly, the differentiation process can be influenced by cytokines which are differentially 
secreted mainly by APCs and other T cells depending on the encountered pathogen. Naïve 
CD4+ T cells differentiate into T helper (Th) cells which can participate in both humoral and 
cell-mediated immunity whereas CD8+ T cells differentiate into cytotoxic T lymphocytes (CTL) 
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that mediate killing of virally infected and tumourigenic cells. A common feature of all effector 
T cells is that they can act independently of further costimulation upon encounter with their 
antigen in the periphery.  
 
1.1.4 T cell subtypes 
 
1.1.4.1  T Helper cells 
The process of antigen-specific T cell activation serves several purposes. One of them is that 
it facilitates the generation of sufficient amounts of T cells which are specific for a given 
antigen through the process of clonal expansion. Another important aspect is that it allows 
tailoring the upcoming immune response specifically to the ongoing immune challenge. The 
polarisation of naïve CD4+ Th (Th0) cells into specialised subsets is therefore pivotal for 
mounting an effective response to diverse types of pathogens. Originally, two distinct subsets 
of Th cells were defined according to their cytokine secretion patterns and functions: The 
T helper cell 1 (Th1) and the T helper cell 2 (Th2) (Mosmann et al., 1986; Mosmann and 
Coffman, 1989). More recent studies have indicated that Th0 cells can also differentiate into a 
different lineage which was termed T helper cell 17 (Th17) due to their ability to produce the 
pro-inflammatory cytokine IL-17A and other molecules of this family (Harrington et al., 2005). 
The differentiation of Th0 cells into different subtypes depends on the conditions under which 
the cells are activated. It has been shown that the amount of antigen, the presenting APC 
type and the cytokine milieu affect this decision process (Croft et al., 1992; Constant and 
Bottomly, 1997; Rothöft et al., 2003).  
 
In the presence of intracellular pathogens or engulfed fungi, professional APCs begin to 
secrete the cytokine IL-12 to which Th0 cells respond with the transcription of the master 
regulators T-box expressed in T cells (T-bet) and signal transducer and activator of 
transcription 4 (STAT4) (Szabo et al., 2000). This in turn promotes the development of Th1 
effector cells which are crucial for immune responses against intracellular pathogens such as 
bacteria, viruses and fungi. Th1 cells exert their function by secreting Interferon gamma 
(IFN- ) and several other pro-inflammatory cytokines such as tumour necrosis factor alpha 
(TNF- ), lymphotoxin alpha, IL-2 and IL-3. These act by enhancing the antimicrobial activity 
of innate immune cells, promote the production of immunoglobulin (Ig) G2a antibodies and 
lead to the recruitment of other lymphocytes and NK cells (Zhu and Paul, 2008). 
Furthermore, IFN-  augments the production of IL-12 by APCs which promotes the 
differentiation of additional Th1 cells while the development of Th2 cells is blocked (So et al., 
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2000). In addition to serving as a growth factor, IL-2 also stimulates the proliferation of CTL 
and promotes the formation of Th1 memory cells (Darrah et al., 2007). Thus, Th1 cells are 
important contributors to cell-mediated immune responses against intracellular pathogens 
and fungi. 
 
Contrariwise, extracellular bacteria and parasites trigger the production of IL-4 which largely 
derives from NKT cells and polarises naïve CD4+ T cells to differentiate towards the Th2 
lineage. In addition, low levels of antigen presented on APCs also favour the development of 
this lineage. The differentiation process is regulated by the master transcription factors GATA 
binding protein 3 (GATA3) and STAT6 (Yamashita et al., 2004). Th2 cells are characterised 
by a cytokine expression pattern which differs from that of Th1 cells and includes IL-4, IL-5, 
IL-6, IL-10 and IL-13 (Zheng and Flavell, 1997). These skew adaptive immunity towards a 
humoral immune response by stimulating B cell proliferation, promoting the generation of 
IgG1 and IgE antibodies and by affecting innate immune cells in several ways. IgE binds to 
receptors on eosinophil granulocytes and mast cells which leads to the release of 
inflammatory mediators such as histamine and leukotrienes that play important roles in the 
resistance to parasite infections (Wedemeyer et al., 2000). Th2 cytokines also have profound 
effects on non-immune cells and cause goblet cell hyperplasia, muscle hyper-contractility 
and excessive mucus production in the airways during allergic responses (Venkayya et al., 
2002). Furthermore, IL-4 stimulates the differentiation of additional Th2 cells from naïve CD4
+ 
T cells whereas IL-10 inhibits the production of IL-2, IL-12 and IFN-  from T cells and APCs 
thus further stabilising the Th2 response. 
 
In addition to the Th1 and Th2 lineages, it has been found more recently that Th17 cells form a 
third important subpopulation of Th cells. Polarization of these cells is triggered in the 
presence of IL-6 and transforming growth factor beta (TGF- ) which activate the transcription 
factors retinoic-acid-receptor-related orphan receptor alpha (ROR ) and gamma t (ROR t) as 
well as STAT3 (Weaver et al., 2006; Iwanov et al., 2006; Yang et al., 2007; Yang et al., 
2008). Upon activation, Th17 cells secrete the cytokines IL-17A, IL-17F, IL-21, IL-22 and 
granulocyte macrophage colony-stimulating factor (GM-CSF) (Ouyang et al., 2008). Although 
the precise role of this population is yet to be established, it is believed that Th17 cells play a 
critical role in mucosal immunity and the defence against certain microbial pathogens, such 
as extracellular bacteria and fungi but also in tumour regression (Weaver et al., 2006; Martin-
Orozco et al., 2009). In this context, the recruitment and activation of innate immune cells 
such as neutrophil granulocytes and macrophages appears to be a central mode of action 




1.1.4.2 Regulatory T cells 
In addition to protecting the host from infections, one important task of the immune system is 
to maintain tolerance to self. The vast majority of potentially autoreactive cells are removed 
in the thymus by mechanisms of central tolerance but some avoid detection and escape into 
the periphery. Regulatory T (Treg) cells are essential for the maintenance of peripheral 
tolerance by preventing the activation of autoreactive cells. In addition, they are also 
important for protecting the host from overshooting immune responses against pathogens 
which could cause additional tissue damage. Treg cells can be classified into naturally 
occurring (nTreg) and inducible (iTreg) cells. The former constitutively express CD25 and the 
transcription factor forkhead box P3 (FoxP3) which is essential for their development and 
function (Fontenot et al., 2003). They arise from DP cells in the thymus which show an 
intermediate affinity for self antigen and are thus potentially autoreactive (Itoh et al., 1999; 
Jordan et al., 2001). On the other hand, iTreg cells develop from naïve T cells in the periphery 
which are activated under sub-immunogenic or non-inflammatory conditions and can be 
further subdivided into several populations (Dons et al., 2012). A common feature of all Treg 
cells is that they are hypoproliferative upon stimulation and can suppress the activation, 
proliferation and cytokine secretion of conventional T cells (Shevach, 2009). This is achieved 
by different means such as the induction of apoptosis in effector T cells, the modulation of 
the environment through anti-inflammatory cytokines or the competition for survival- and 
activation signals (Sakaguchi et al., 2009). Hence Treg cells are an important subset of T cells 
which is critical for the control of normal immune responses and for self-tolerance. 
 
1.1.4.3 Cytotoxic T cells 
CTLs are the main antigen-specific effector cells of cell-mediated immune responses. They 
are crucial for controlling infections by cytoplasmic bacteria, viruses and some intracellular 
protozoan parasites which are beyond the reach of the humoral immune system. In addition, 
they have also proven to be the most important effector T cells in immune responses against 
tumours. Once activated, CTLs can rapidly and selectively kill infected cells with high 
efficiency by two different means (Henkart et al., 1994). The first mechanism is based on 
preformed effector molecules which are stored in lytic granules and are released upon TCR 
cross-linking. These vesicles contain perforin which polymerises to form transmembrane 
pores in the target cells membrane and a set of serine proteases called granzymes that 
move through these pores into the target cells and induce apoptosis via caspase activation 
(Kuppers and Henney, 1977). In the course of apoptosis, viral DNA as well as non-viral 
cytosolic pathogens are destroyed which prevents the infection of adjacent cells. A second 
mode of action involves surface expression of Fas ligands which also cause apoptosis in 
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target cells that bear the appropriate receptor (Suda et al., 1993). Finally, CTLs can act via 
the secretion of cytokines. IFN- , which is produced in large quantities, inhibits viral 
replication, promotes increased expression of MHC class I molecules on target cells and 
causes recruitment and activation of macrophages. In addition, CTLs secrete TNF-  and 
TNF-  which synergise with IFN-  in macrophage activation and can kill cells through 
interaction with TNFR-1. 
 
1.2 The hedgehog signalling pathway 
 
1.2.1 Basic concepts 
One decisive step during the evolution of life was the emergence of multicellular organisms 
which appeared approximately 1,2 billion years ago. Multicellularity however required the 
development and refinement of mechanisms that allowed interaction and communication 
between adjacent and distant cells. During the last decades, extensive research has unveiled 
many key molecular players in this context which led to the surprising finding that evolution 
has been working with a rather limited number of signalling pathways to generate the 
tremendous diversity and complexity of multicellular life. These include the TGF- , the Janus 
kinase (JAK) and signal transducer and activator of transcription (STAT), the epidermal 
growth factor receptor (EGFR), the fibroblast growth factor (FGF) as well as the Notch, Wnt 
and Hedgehog (Hh) signalling pathways. Early studies of Hh signalling were exclusively 
based on genetic analysis in the fruit fly Drosophila melanogaster where it was originally 
identified and recognised as an important factor for proper segmental patterning during 
embryogenesis (Nüsslein-Volhard and Wieschaus, 1980; Forbes et al., 1993). Further 
investigations revealed that this pathway is not only implicated in the embryonic development 
of both invertebrates and vertebrates but also plays an important role in the maintenance of 
many adult structures. It has been shown to regulate proliferation, differentiation and cell fate 
determination of progenitor cells that give rise to various tissues such as epithelia, neuronal 
structures and others (Beachy et al., 2004; Watkins et al., 2003; Machold et al., 2003; Palma 
and Ruiz i Altaba, 2004). The central importance of this pathway for tissue development and 
homeostasis is clearly demonstrated by the fact that aberrant signalling contributes to severe 
developmental abnormalities such as Gorlin syndrome, holoprosencephaly and cyclopia 
(Hahn et al., 1996; Chiang et al., 1996; Rössler et al., 1996; Nieuwenhuis & Hui, 2005) while 
complete loss of Hh signalling is embryonically lethal (Goodrich et al., 1997; Hahn et al., 
1998). Importantly, mutations in Hh signalling components that lead to constitutive pathway 
activation are also associated with oncogenesis and can cause basal cell carcinoma (BCC), 
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medulloblastoma (MB) and rhabdomyosarcoma (RMS) (Hahn et al., 1996; Goodrich et al., 
1997; Hahn et al., 1998). A detailed understanding of Hh signalling function and its beneficial 
or adverse effects on the organism requires knowledge of the different pathway components 
and how they interact which each other. 
 
1.2.2 Major pathway components 
A hallmark of Hh signalling is its ability to act over a long range and control distinct cell fates 
as a function of Hh concentration. The principal mediators of this long range communication 
are proteins of the Hh family. While there is only one Hh gene in Drosophila and other 
invertebrates, three homologues have been identified in birds and mammals which were 
called Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian hedgehog (Ihh) (Krauss et 
al., 1993). Other vertebrates may have additional family members such as the zebrafish 
which harbours six Hh genes following gene duplication (Avaron et al., 2006). The various 
Hh proteins are believed to mainly differ in their tissue distribution with Shh being the most 
widely expressed family member (Ingham & McMahon, 2001). Hh proteins are synthesised 
as precursor proteins with a size of approximately 45 kDa. Following translation, they 
undergo autocatalytic cleavage which yields two fragments of almost identical size. The 
C-terminal fragment contains a highly conserved ‘Hog’ domain that catalyses the 
autocleavage reaction and is quickly degraded. The ‘Hedge’ domain carrying N-terminal 
fragment (Hh-N) however is covalently bound to cholesterol, a modification which is essential 
for its signalling activity (Porter et al., 1996). Subsequently, Hh-N is subject to another 
modification mediated by Hh acetyltransferase (Hhat) which catalyses the attachment of 
palmitate, a derivative of palmitic acid (Chamoun et al., 2001). The addition of this second 
lipid moiety is believed to further enhance activity and tissue distribution of the protein by 
promoting the formation of freely diffusible multimeric complexes (Zeng et al., 2001; Vyas et 
al., 2008). Finally, release of the modified Hh-N from the signal-sending cell requires the 
activity of a 12-pass transmembrane protein called Dispatched (Disp) which shows homology 
to the resistance-nodulation-division (RND) family of bacterial transporters (Burke et al., 
1999). Both the exact mechanism of Hh-N secretion and the process that leads to the 
formation of multimeric complexes at the surface of vertebrate cells remain uncertain. Once 
released into the intercellular space, Hh-N complexes can bind to receptors on signal-
receiving cells.  
 
The main receptor for Hh is Patched1 (hereinafter referred to as Ptch) which, like Disp, also 
shows homology to the RND family of bacterial transporter proteins and has a high affinity for 
Hh ligands (Goodrich et al., 1997; Marigo et al., 1996). In mammals, the receptor has a 
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length of approximately 1.500 amino acids and contains 12 hydrophobic membrane-
spanning domains, a sterol-sensing domain (SSD) which can also be found in many 
cholesterol-binding proteins, two large extracellular loops where binding of the Hh ligands 
occurs, a central intracellular loop that mediates interaction with cyclin B1 and a C-terminal 
cytoplasmic tail (Figure 1) (Hooper and Scott, 1989; Marigo et al., 1996; Barnes et al., 2001; 
Strutt et al., 2001; Martín et al., 2001). RND-type transporters are almost exclusively found in 
bacteria were they pump lipophilic toxins and heavy metals out of the cell. The finding that 
mutations of amino acids which are crucial for transporter activity negatively affects Ptch 
function suggests that it might perform a similar task in eukaryotic cells (Taipale et al., 2002). 
Mammals also have a second Ptch receptor (Ptch2) which is structurally similar to Ptch and 
Disp (Zaphiropoulos et al., 1999). It is however somewhat smaller in size and lacks a C-
terminal cytoplasmic extension which is present in Ptch. Both are differentially expressed 
during mouse development but while Ptch2 is also fully capable of binding Hh ligands, the 
finding that it cannot compensate for lacking Ptch in BCCs suggests that it may have related, 
yet distinct functions when compared with Ptch (Motoyama et al., 1998; Carpenter et al., 
1998; Zaphiropoulos et al., 1998).  
 
Figure 1. Schematic view of Ptch 
Ptch is a 12-pass transmembrane 
protein with two characteristic 
extracellular loops that mediate 
ligand binding, a central intra-
cellular loop that contains a cyclin 
B1 interaction domain (blue), a 
sterol-sensing domain that spans 
over transmembrane domains 2-6 
(red) and a C-terminal cytoplasmic 
tail. 
 
Reception of Hh ligands by Ptch is supported by several surface proteins that act as 
presumptive co-receptors. These include the single-pass transmembrane proteins cell 
adhesion molecule down-regulated by oncogenes (CDO) and brother of CDO (BOC) which 
belong to the family of immunoglobulin- and fibronectin type III (FnIII)-containing membrane 
proteins (Lum et al., 2003; Tenzen et al., 2006). Mice lacking either one of these proteins are 
viable but display signs of disturbed Hh signalling while those deficient for both co-receptors 
exhibit more severe signalling defects (Zhang et al., 2006; Zhang et al., 2011). Thus, both 
proteins are not mandatory for signal transduction but act in a redundant fashion to enhance 
Ptch-mediated signalling. While both co-receptors are orthologues of Drosophila proteins, 
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vertebrates harbour additional and structurally distinct Hh-binding proteins with one of them 
being growth arrest-specific gene 1 (GAS1) (Del Sal et al., 1992; Allen et al., 2007). 
Interestingly, it has been shown that inactivation of GAS1 in mice that already lack CDO and 
BOC leads to a complete loss of Hh signalling thus emphasizing the requirement for co-
receptors during Hh ligand reception (Allen et al., 2011). Analogous to Drosophila where the 
interaction of co-receptors with Hh ligands is only possible in the presence of heparin, it was 
found that mammalian orthologues require high concentrations of calcium ions to mediate 
ligand binding showing that co-receptor requirement but not the mode of Hh binding is 
conserved across different phyla (McLellan et al., 2008). Finally, with Hedgehog-interacting 
protein (HIP) vertebrates possess a fourth protein that is capable of binding Hh ligands. HIP 
has no downstream signalling function and is believed to modulate signalling by directly 
competing with Ptch for Hh binding and by ligand sequestration (Chuang et al., 1999).  
 
The major pathway component that acts downstream of Ptch is Smoothened (Smo) which 
belongs to the seven-transmembrane G protein-coupled receptor (GPCR) superfamily and is 
indispensable for Hh signalling both in Drosophila and in vertebrates (Alcedo et al., 1996; 
van den Heuvel et al., 1996; Kristiansen, 2004). Unlike most other members of this family, 
Smo possesses a long C-terminal domain that contains several conserved phosphorylation 
sites which are required for Hh-dependant signalling (Apionishev et al., 2005). Indeed, 
phosphorylation is the crucial step that leads to a conformational change which causes 
recruitment and activation of Smo. Phosphorylation is mediated by the 3′,5′-cyclic adenosine 
monophosphate (cAMP)-dependent G protein-coupled receptor kinase 2 (GRK2) and casein 
kinase 1 alpha (CK1 ) in the presence of Hh ligand (Phillipp et al., 2008; Chen et al., 2011). 
Consistent with its GPCR-like topology, Smo has also been shown to regulate Hh signalling 
through the direct interaction with a specific family of heterotrimeric GTP-binding proteins 
(Riobo et al., 2006; Ogden et al., 2008).  
 
Ultimately, Smo modulates abundance and activity of the glioma-associated oncogene (Gli) 
family of zinc finger transcription factors. Mammals possess three Gli proteins (Gli1-3) which 
constitute the principal effectors of canonical Hh signalling (Aza-Blanc and Kornberg, 1999; 
Alexandre et al., 1996). They consist of a N-terminal transcriptional repressor domain and a 
C-terminal transcriptional activator domain. In the absence of Hh ligand, Gli proteins exist in 
both the full-length form (Gli-FL) and the proteolytically processed form that lacks the 
C-terminal activator domain and therefore acts as a transcriptional repressor (Gli-R). Upon 
Hh stimulation, processing into the repressor form is largely inhibited and the Gli proteins 
accumulate in the nucleus where they are modified to become transcriptional activators 
(Gli-A). Both the processing into transcriptional repressors and the rapid removal of 
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transcriptional activators is controlled by the ubiquitin-proteasome system (Jiang, 2006). Gli2 
and Gli3 are principally bi-functional transcription factors and can act both as an activator or 
a repressor form with Gli3 mainly acting as a transcriptional repressor (Person et al., 2002). 
In contrast, Gli1 lacks the N-terminal repressor domain and functions exclusively as a 
transcriptional activator (Bai et al., 2004). Its transcription is largely increased during a 
positive feedback-loop in response to active signalling and thus it is widely used as a 
biomarker for increased canonical signalling activity (Park et al., 2000). Both repressor and 
activator forms of Gli largely bind to the same sites in the promoters of Hh target genes and 
regulate the expression of hundreds of genes in response to Hh ligands (Müller and Basler, 
2000; Hallilas et al., 2006; Vokes et al., 2008).  
 
1.2.3 Signal transduction 
Although many aspects of Hh signalling are conserved across metazoans, it has become 
evident in recent years that this pathway is coupled to a specific cellular organelle in 
mammals, the primary cilium (Oro, 2007). Interestingly, this requirement has not only been 
demonstrated for mammals but also for amphibians (Park et al., 2006), birds (Yin et al., 
2009) and fish (Huang and Schier, 2009) suggesting that it is a common feature of Hh 
signalling in vertebrates. This is different from Drosophila where primary cilia are dispensable 
for Hh signalling activity which can be explained by the absence of these structures in most 
cell types (Götz et al., 2009). Primary cilia are cellular organelles which protrude from the 
surface of most vertebrate cells (Bettencourt-Dias et al., 2011). Similar to conventional cilia, 
the axoneme of primary cilia is made up of microtubule pairs in a characteristic 9-fold 
symmetric organisation and is anchored to the plasma membrane through the basal body. 
Due to the lack of key elements involved in ciliary motility including the central pair of 
microtubules, primary cilia are immotile structures. Thus they have been regarded as 
vestigial organelles without important function until they have recently emerged as important 
regulators of several developmental signalling pathways including the Hh signalling pathway 
(Huangfu et al., 2003, May et al., 2005). Different studies have shown that components of the 
Hh pathway including Ptch (Rohatgi et al., 2007), Smo (Corbit et al., 2005), Sufu (Zeng et al., 
2010) and the Gli transcription factors (Haycraft et al., 2005) are enriched in primary cilia. 
Notably, localisation of Hh signalling components in motile cilia could not be demonstrated 
and Hh signalling was not affected when the formation of these organelles was disrupted 
either (Wilson et al., 2009; Fliegauf et al., 2007). Although the precise interaction between Hh 
signalling and primary cilia is not fully understood, recent investigations have identified the 
kinesin Kif7, a component of the intraflagellar transport machinery, as a major factor which 
tethers the Hh signalling pathway to the primary cilium by directly interacting with Hh 
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components (Cheung et al., 2009; Endoh-Yamagami et al., 2009; Liem et al., 2009). A 
second finding which has been made during the past few years and which has expanded the 
understanding of the Hh signalling pathway is that Hh proteins can transduce signals into the 
cell by different means. A signal transduction that involves the Gli transcription factors and 
follows the central Ptch-Smo-Gli axis is classically referred to as canonical signalling while 
Gli-independent mechanisms are summarised under the term “non-canonical signalling”. 
 
1.2.3.1 Canonical signalling 
In the absence of a ligand, the Hh receptor Ptch localises to the base of the primary cilium 
and prevents Smo from entering the organelle by maintaining it in an inactive conformation 
(Figure 2) (Hammerschmidt et al., 1997; Goodrich et al., 1999; Rohatgi et al., 2007). The 
precise mechanism by which Smo repression occurs is not well understood. Although initial 
studies proposed that a direct interaction between both transmembrane proteins takes place 
(Murone et al., 1999), the finding that Ptch-mediated inhibition occurrs non-stoichiometrically 
suggested that an indirect mechanism is employed instead (Taipale et al., 2002). Concerning 
the sequence similarities between Ptch and the RND family of bacterial transporters and the 
presence of its sterol-sensing domain, it has thus been hypothesised that Ptch regulates 
Smo catalytically through local changes in the concentration of small molecules such as 
sterols or lipids (Taipale et al., 2002; Chen et al., 2002). Different classes of oxidised 
derivatives of cholesterol (oxysterols) and phosphatidylinositol-4-phosphate (PI4P) have 
been proposed as mediators of Ptch-mediated repression (Biilsma et al., 2006; Corcoran and 
Scott, 2006; Yavari et al., 2010). While Smo is retained in an inactive conformation, Gli2-FL 
and Gli3-FL form a complex with suppressor of fused (Sufu) at the base of the primary cilium. 
This interaction stabilises and sequesters the transcription factors in the cytosol thus 
preventing their nuclear translocation (Humke et al., 2010; Wang et al., 2010). In addition, 
Sufu promotes the phosphorylation of C-terminal amino acid residues in Gli-FL by protein 
kinase A (PKA). This allows further phosphorylation by glycogen synthase kinase 3 beta 
(GSK-3 ) and CK1  (Tempé et al., 2006; Kise et al., 2009). The kinesin-4 family member 
Kif7 which acts as a scaffold-protein and binds to the Sufu-Gli complex is thought to facilitate 
the phosphorylation process (Liem et al., 2009, Cheung et al., 2009; Endoh-Yamagami et al., 
2009). Fully phosphorylated Gli-FL is subsequently recognised by the E3 ubiquitin ligase 
beta-transducin repeat containing protein ( -TrCP) which leads to the ubiquitylation of Gli-FL. 
The full length transcription factors are then partially proteolysed in a manner that degrades 
only the C-terminal activation domain, yielding the transcriptional repressors form (Gli-R) of 
the proteins (Humke et al., 2010). The truncated Gli-R proteins then translocate into the 





Figure 2. The canonical hedgehog signalling pathway 
(A) In the absence of Hh ligands, Ptch localises to the base of the primary cilium from where 
it maintains Smo in an inactive conformation. Gli-FL then forms a complex with Kif7 and Sufu 
which prevents its nuclear translocation and promotes the phosphorylation of C-terminal 
residues by PKA, CK1  and GSK-3 . This results in partial proteasomal degradation which 
generates truncated transcriptional repressors that inhibit target gene expression. (B) Upon 
ligand binding, Ptch exits the primary cilium and its inhibition of Smo is abrogated.  
Phosphorylation of Smo by CK1  and GRK2 leads to its activation and translocation into the 
primary cilium where it promotes the disassembly of Sufu-Gli complexes. Gli is then 
transported into the nucleus where it is converted into a transcriptional activator that 
promotes target gene transcription. (modified from Cell Signalling Technology, 
www.cellsignal.com) 
 
Canonical signalling is activated in the presence of Hh ligands. The multimeric protein 
complexes are recognized by the Hh receptor Ptch and binding is facilitated by the co-
receptors CDO, BOC and GAS1 which interact with Hh proteins through their FnIII repeats 
(Beachy et al., 2010). This interaction causes Ptch to exit the primary cilium and relieves its 
inhibition of Smo. Subsequently, the C-terminal tail of Smo becomes phosphorylated by 
CK1  and GRK2 which leads to a conformational change of the protein thus triggering its 
activation (Chen et al., 2011). In addition, the phosphorylation event recruits -arrestins and 
the kinesin-2 motor subunit Kif3a to Smo which mediate its transport into the primary cilium 
(2004 Chen et al., 2008 Kovacs et al., 2009 Milenkovic et al.). Along with Smo, Sufu-Gli 
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complexes are also transported to the tip of the primary cilium by the kinesin Kif7. Although 
the exact mechanism remains poorly understood, activated Smo is likely to promote the 
dissociation of Sufu-Gli complexes at the cilium tip and thus inhibit Gli processing into the 
repressor form (Humke et al., 2010; Tukachinsky et al., 2010). Kif7 presumably assists in the 
disassembly of the Sufu-Gli complex (Liem et al., 2009; Endoh-Yamagami et al., 2009). 
Following the liberation from Sufu, Gli-FL is actively transported along microtubules into the 
nucleus where it is converted into its activator form (Kim et al., 2009; Tukachinsky et al., 
2010). The details of this conversion process also remain uncertain but are likely to involve 
phosphorylation events which promote the removal of the N-terminal repressor domain 
(Humke et al., 2010). Eventually, Gli-A promotes transcription of genes involved in 
differentiation, proliferation and cell survival as well as several positive and negative 
regulators of the pathway such as Gli1, Ptch, and HIP (Goodrich et al., 1996; Chuang et al., 
1999). 
 
1.2.3.2 Non-canonical signalling 
The components involved in canonical Hh signalling and their interactions have been 
intensely studied since the discovery of the pathway. In recent years however, numerous 
observations suggested that Hh proteins can also transduce signals into cells through 
different mechanisms (Jenkins et al., 2009). Cellular responses to Hh ligands which do not 
involve activation of the Gli transcription factors are collectively referred to as non-canonical 
signalling. According to current experimental evidence, two different classes of Gli-
independent signalling can be defined: Type I which solely depends on Ptch and is unrelated 
to its repression of Smo and type II which requires Smo function.  
 
1.2.3.2.1 Type I 
Early evidence for the ability of Ptch to function independent of canonical pathway 
components came from observations that its overexpression induced apoptosis in different 
cell lines (Thibert et al., 2003). This effect was independent of Smo function and did not 
cause the activation of canonical signalling. In this context, Ptch has been proposed to 
function as a “dependence receptor” meaning that cell survival depends on the presence of 
Hh ligands while apoptosis is actively induced when the ligand is removed (Bredesen et al., 
2004; Mehlen and Thibert, 2004). Indeed, it has been reported that the C-terminal 
cytoplasmic domain of Ptch is a substrate for several caspases and that it is essential for 
apoptosis induction (Thibert et al., 2003). Additional studies revealed that Ptch-induced 
apoptosis is preceded by the recruitment of caspase 9, the caspase-interacting protein 
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Tucan-1 and the adaptor protein Dral which form a pro-apoptotic complex at its C-terminal 
domain (Mille et al., 2009). Support for this hypothesis comes from observations that the C-
terminal domain is not required for canonical Hh signalling but appears to be associated with 
the regulation of proliferation and/or apoptosis (Sweet et al., 1996; Makino et al., 2001). A 
different function of Ptch in cellular regulation that is independent of Hh signalling 
components was reported by Barnes and colleagues (2001). They showed that Ptch can 
bind the phosphorylated but not the unphosphorylated form of the cell cycle regulator cyclin 
B1 with its large intracellular loop. Overexpression of Ptch in vertebrate cell culture led to a 
redistribution of cyclin B1 from the nucleus to the cytoplasm and negatively affected cell 
proliferation. Interestingly, binding of Hh to Ptch suspended this interaction and allowed 
nuclear translocation of cyclin B1 thus promoting proliferation. A later study provided 
mechanistic insights into the interaction between Ptch and cyclin B1. It was shown that the 
dissociation of this complex involved interaction between Ptch and GRK2, the kinase which 
is also implicated in the activation of Smo during canonical pathway activation (Jiang et al., 
2009). Taken together, several lines of evidence suggest that Ptch can modulate proliferation 
and apoptosis upon Hh binding by mechanisms that are independent of components of the 
canonical signalling pathway. 
 
1.2.3.2.2 Type II 
The discovery that Smo can act as a GPCR and selectively interact with inhibitory 
heterotrimeric G (Gi) proteins had important consequences for the understanding of Hh 
signalling (Riobo et al., 2006). Only recently, it was reported that Hh proteins could promote 
the formation of actin filaments and microtubules in endothelial cells in the absence of 
canonical pathway activation (Chinchilla et al., 2010). This effect was shown to be dependent 
on Smo and on Gi protein-mediated activation of RhoA, a member of the Rho family of small 
GTPases which are known to regulate cytoskeletal reorganisation (Sit and Manser, 2011). A 
different study demonstrated that Hh proteins could also stimulate the migration of fibroblasts 
by a mechanism which involved Gi proteins but was independent of Gli activation (Polizio et 
al., 2011). Furthermore, the requirement for Smo-mediated activation of phosphoinositide 
3-kinase (PI3K) was shown which led to the activation of the Rho family members RhoA and 
Rac1. The exact mechanism by which Rho GTPases are activated by Smo has not yet been 
elucidated but a recent report suggested that Smo interaction with specific guanine 
nucleotide exchange factors (GEF) such as T-lymphoma invasion and metastasis 1 (Tiam-1) 
might also be involved (Sasaki et al., 2010). Other reports focussed on the ability of Hh 
proteins to guide the growth of axons in the developing nervous system. It was found that 
Shh could act either as an attractive or repulsive factor for different axon types. The 
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mechanism by which Shh directed axon growth was shown to be Smo-dependent but Gli-
independent and involved activation of the Src family kinases Src and Fyn instead (Yam et 
al., 2009). Interestingly, it has been reported by another group that Src kinases can directly 
associate with the C-terminal tail of Ptch via SH3 domains (Chang et al., 2010). Yet other 
studies have suggested that metabolites of arachidonic acid such as leukotrienes might be 
involved in Smo-dependent but Gli-independent signal transduction that causes cytoskeletal 
remodelling. This assumption was based on the observation that addition of Shh to cultured 
fibroblasts promoted lamellipodia-formation and migration which could be inhibited by 
treatment with inhibitors of 5-lipoxygenase, a key enzyme in the biosynthesis of leukotrienes 
(Bijlsma et al., 2007; Polizio et al., 2011). Finally, it was also suggested that calcium ions 
may act as second messengers in Smo-dependent but Gli-independent responses to Hh 
ligands (Belgacem and Borodinsky, 2011). In the context of spinal cord development, it was 
speculated that Gi protein-mediated activation of phospholipase C gamma (PLC- ) led to the 
release of calcium ions from the endoplasmic reticulum (ER) thereby affecting cellular 
behaviour. In summary, experimental data from several different studies suggest that Hh 
proteins can affect cellular responses by modulating cytoskeletal organisation through a 
variety of Gli-independent mechanisms. Although the underlying principles are far from being 
well understood, Smo appears to have a central role in these processes by directly 
interacting with specific G proteins, small GTPase-associated proteins and kinases.  
 
1.2.4 Role of hedgehog signalling in haematopoiesis 
The term haematopoiesis describes the generation of cellular blood constituents from 
multipotent progenitor cells. In vertebrates, this process can be broadly divided into two 
major phases based on the stage of development (Keller et al., 1999). Primitive 
haematopoiesis occurs predominantly in the yolk sac and is characterised by the 
commitment of embryonic mesoderm to haematopoietic precursor cells (Wong et al., 1986) 
while definite haematopoiesis starts with the formation of multipotent haematopoietic stem 
cells (HSC) later in embryonic development (Medvinsky et al., 1996). HSCs constitute a 
self-renewing cell population that can mature into multipotent progenitors (MPP) which in turn 
give rise to the two major lineages of haematopoietic cells, the myeloid and the lymphoid 
lineage (Lemischka et al., 1986). Early evidence that Hh signalling might play a role in 
haematopoiesis came from observations of Bhardwaj and colleagues who reported that all 
major components of the canonical Hh signalling pathway were expressed in primitive 
human cord blood HSCs (Bhardwaj et al., 2001). In addition, the authors reported that 
stimulation with exogenous Shh resulted in an increased proliferative capacity of HSCs. 
Similar observations were also made by another group which found that Ptch 
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haploinsufficiency enhanced HSC proliferation during haematopoietic recovery (Trowbridge 
et al., 2006). Further investigations suggested that Hh signalling may also be important in the 
differentiation of haematopoietic cells such as during erythropoiesis (Detmer et al., 2005; 
Cridland et al., 2009). While these studies proposed that Hh pathway activity was required 
for haematopoiesis, others reports suggested that it was dispensable. By conditional 
inactivation of Smo in HSCs, Dierks and colleagues found that the proliferative capacity of 
these cells remained unaltered (Dierks et al., 2008). This was supported by the findings of 
two other groups which employed different strategies to inactivate Smo in HSCs (Hofmann et 
al., 2009; Gao et al., 2009). Taken together, the role of Hh signalling in HSC function and 
haematopoietic differentiation remains controversial due to conflicting data obtained from 
different experimental approaches.  
 
Several studies have also been conducted to elucidate the role of Hh signalling in the 
development and function of T lymphocytes. As with HSCs, major components of the 
canonical Hh signalling pathway including Hh, Ptch, Smo and Gli are expressed in the 
vertebrate thymus suggesting that this pathway might play a role in thymopoiesis (Outram et 
al., 2000; Sacedon et al., 2003). Indeed, early studies that investigated Hh signalling in fetal 
thymus organ culture (FTOC) found that Hh signals were differentially required for the 
development of thymocytes. It was reported that transition from DN to DP cells was 
enhanced in the absence of Shh signals while transition to the SP stage required Shh 
(Outram et al., 2000). Subsequent work which studied thymocyte development using FTOC 
in Shh-/- mice however found that Shh signals were required both for the transition from DN1 
to DN2 and from DN4 to DP stage (Shah et al., 2004; Hager-Theodorides et al., 2005). The 
work of Uhmann and colleagues supported a role for Hh signalling at these developmental 
stages but demonstrated that Ptch ablation blocked rather than promoted these transition 
events (Uhmann et al., 2007). In addition, they reported that Ptch ablation led to a severe 
developmental block at the stage of CLP which affected both T and B lymphocyte 
development. Later work revealed that T cell-intrinsic expression of Ptch was dispensable for 
T cell development and it was suggested that expression of Ptch in pre-thymic stromal cells 
was required instead (Uhmann et al., 2011). Yet, most reports focussed on the role of Hh 
signalling during intrathymic development. By analysing conditional or T lineage-specific Smo 
ablations in vivo, El Andaloussi and colleagues reported that Hh signalling was crucial for 
survival and differentiation of early thymocyte progenitors (ETP) but became dispensable 
after pre-TCR expression at the DN3 stage. Other groups however challenged this statement 
and claimed that Hh signalling was also required for thymocyte development beyond the 
DN3 stage. By employing a mouse model that expressed a constitutively active form of the 
transcription factor Gli2 (Gli2 N2) thus mimicking an active pathway, it was reported that Hh 
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signalling negatively affected the strength of the TCR signal (Rowbotham et al., 2007). This 
had implications for intrathymic selection processes since it reduced positive selection of 
thymocytes and allowed self-reactive cells to escape clonal deletion. Overexpression of 
Gli2 N2 also caused a shift in the CD4 to CD8 ratio among thymocytes by promoting the 
development of CD4+ SP cells from DN cells which affected the peripheral T cell composition 
as well. Importantly, not only thymocyte development and composition of peripheral T cells 
were affected in this model but also peripheral T cell function. Due to the attenuation in TCR 
signal strength, T cells responded to stimulation with reduced proliferation and expression of 
activation markers. When a different variant of Gli2 was expressed which lacked the 
C-terminal activation domain and thus acted as a constitutive transcriptional repressor 
(Gli2 C2), T cells were found to be hyperreactive thus supporting the notion that Hh 
signalling was a negative regulator of T cell function (Rowbotham et al., 2008). However, 
these findings were contrary to previous reports which aimed at elucidating a potential 
implication of the Hh signalling pathway in the function of mature T cells in vitro. Stewart and 
colleagues treated polyclonally activated human CD4+ T cells with recombinant Shh (rShh) 
and evaluated its effect on T cell activation. They found that rShh enhanced proliferation, 
secretion of cytokines (IL-2, IFN- , IL-10) and the expression of activation markers (CD25, 
CD69) under already optimal stimulation conditions (Stewart et al., 2002). Addition of 
neutralising antibodies against Shh had opposite effects which supported the previous 
observations and suggested that T cells secrete Shh upon activation that acts in an autocrine 
fashion. When the experiments were performed with murine CD4+ T cells, it was observed 
that rShh was only able to enhance the proliferation of suboptimally activated cells and had 
no effect on resting T cells (Lowrey et al., 2002). It was further demonstrated that Shh 
amplified proliferation by enhancing cell entry into the S-G2 phase of the cell cycle and by an 
increased expression of the anti-apoptotic gene B-cell lymphoma 2 (Bcl-2). These findings 
were supported by the work of another group which also studied the effect of rShh on T cells 
in vitro. Chan and colleagues reported that exogenous Shh enhanced proliferation and 
cytokine secretion of suboptimally stimulated T cells (Chan et al., 2006). In addition, 
microarray analysis revealed that Shh treatment caused the upregulation of a subset of 
genes which was similarly regulated by CD28 signalling. Thus the authors speculated that 
the Hh signalling pathway might constitute a novel costimulatory pathway in T cells. 
 
In summary, several studies tried to elucidate the function of Hh signalling in haematopoietic 
cells and specifically in T cells. Although an implication of this pathway is likely, the currently 
available data is highly contradictory as some reports suggest that Hh signalling is a positive 
regulator of T cell development whereas others propose that it is a negative regulator or that 
it is not implicated at all. There is also disagreement whether a potential implication is limited 
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to the development of T cells or whether it might affect these cells beyond developmental 
stages as well. This demonstrates that additional investigations are required to gain further 
understanding of this important signalling pathway and its role in the haematopoietic system. 
 
1.3 Disease models employed in this study 
 
1.3.1 Allergic airway inflammation 
Allergic airway inflammation represents an experimental model of human asthma which is 
defined as a chronic inflammatory disorder of the airways. It is characterised by reversible 
airflow obstruction, persistent airway hyperresponsiveness, airway inflammation and airway 
remodelling (Bousquet et al., 2000). Since most animals including mice do not spontaneously 
develop a condition with similarity to human asthma, an artificial asthma-like reaction can be 
induced in the airways of laboratory rodents in order to mimic and study the disease. Mouse 
models of acute allergic responses to inhaled foreign proteins such as Ovalbumin (Ova) are 
most commonly used for this purpose. Following an initial sensitisation against a protein 
along with a Th2-promoting adjuvant, mice are reexposed to the allergen by different means 
which typically results in an inflammatory reaction that is characterized by an eosinophil-
dominated influx of inflammatory cells into the lungs, epithelial thickening, and airway 
hyperresponsiveness. In human asthma as well as in experimental models of airway 
inflammation, the observed responses involve a complex interplay between components of 
the innate and adaptive immune system which is still not fully understood. It is known 
however that T cells play a central role during this response. Exposition of sensitised mice to 
the allergen leads to the activation of Th2 cells that orchestrate the following immune 
response in several ways (Corry et al., 1998; Hogan et al., 1998). Production of the Th2 
cytokines IL-4, IL-5, and IL-13 are known to cause many of the features of the disease by 
promoting isotype switching towards IgE in B cells, modulating eosinophil function and by the 
activation of mast cells (Georas et al., 2005). There is also evidence that other T cell 
subpopulations contribute to the pathogenesis of asthma including Treg cells which can 
suppress Th2 cell responses and Th17 cells that seem to be associated with neutrophil 
activation and tissue remodelling (Lewkovich et al., 2005; Bullens et al., 2006). Hence, 
murine models of allergic airway inflammation provide a useful tool for the study of different 




1.3.2 Acute Graft-versus-Host disease 
Graft-versus-Host disease (GvHD) is a common clinical complication following HSC 
transplantation. In humans, the disease can be divided into an acute (aGvHD) and a chronic 
(cGvHD) form which differ in time of onset and in the underlying mechanisms. The acute 
form is generally observed within the first 100 days after transplantation and is characterized 
by selective damage to the liver, skin, mucosa and the gastrointestinal tract. Mouse models 
of aGvHD have provided the majority of insights into the pathophysiology of this disease. 
Early studies already revealed that alloreactive T cells which are contained in the graft and 
transferred into the recipient are the underlying cause of GvHD (Korngold and Sprent, 1978). 
Additional investigations in the following decades led to a much better understanding of how 
T cells contribute to this disease. It was found that donor T cells rapidly migrate to secondary 
lymphoid organs after cell transplantation where they initially become activated by host APCs 
due to mismatched major and minor histocompatibility antigens (Panoskaltsis-Mortari et al., 
2004; Beilhack et al., 2005; van Dijk et al., 1999). This leads to the expansion and maturation 
of several T cells subtypes which contribute to the pathogenesis of GvHD by different means. 
These include Th1 as well as Th2 cells which can both cause GvHD under different conditions 
while aGvHD in mice has been shown to be mainly Th1 biased (Krenger & Ferrara, 1996). 
Most cytotoxic effects however are due to the activity of CTLs which cause extensive tissue 
damage in several organs through the induction of apoptosis and the release of inflammatory 
cytokines (Braun et al., 1996; Baker et al., 1996). More recently, it was reported that Th17 
cells can also contribute to the pathogenesis especially of later stages of GvHD although a 
protective role has been suggested as well (Kappel et al., 2009; Yi et al., 2008). Adverse 
effects of effector T cell activation in GvHD may be counteracted by Treg cells which can 
suppress a wide range of immune responses including alloreactive T cell responses (Edinger 
et al., 2003). Taken together, due to the involvement of various T cells subtypes in a Th1-
biased immune response that can easily be assessed, a murine model of aGvHD provides a 
platform which allows to evaluate a plethora of T cell functions in a physiologic setting. 
 
1.3.3 B16 melanoma model 
Malignant melanoma is a type of cancer which predominantly arises from melanin-producing 
cells (melanocytes) of the epidermis. Several murine models for malignant melanoma have 
been developed over time to gain insights into the mechanisms underlying tumour growth, to 
investigate anti-tumour immune responses and to evaluate novel drugs. These include 
syngeneic transplantation models, xenograft models and models involving genetically 
modified animals. Syngeneic transplantation models such as the B16 melanoma model 
(Fidler, 1973) were first established and have been used for many decades in this context. 
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They rely on the application of a defined number of cultured melanoma cells which are 
subcutaneously or intravenously injected into syngeneic recipients. Depending on the 
application route, these models can be used to study either the development of primary 
tumours under the skin or of single cell metastases in the lung (Overwijk and Restifo, 2001). 
CTLs represent the most effective cell type that mediates killing of neoplastic cells and thus 
have frequently been used as an immunotherapeutic approach in the treatment of melanoma 
(Jäger et al., 1996; 1997 Dufour et al., 1997). Once a tumour is sensed and engaged by the 
innate immune system, tumour-specific CTLs are generated in draining lymph nodes and 
migrate to the tumour site. Here they can successfully recognize and destroy tumour cells 
even when the antigen is expressed on the target cells at very low densities (Melief 1992). 
On the other hand, Treg cells are also recruited in large numbers into the tumour 
microenvironment through chemokines such as CCL22 which is produced by tumour-
infiltrating macrophages and some tumour cells themselves (Ishida et al., 2006; Curiel et al., 
2004). Accumulating Treg cells may become activated and expand in the tumour vicinity after 
recognizing tumour-associated antigens, a process which is further amplified by local 
tolerogenic dendritic cells (Gobert et al., 2009; Su et al, 2010; Ghiringhelli et al., 2005). 
Activated Treg cells can then suppress the function of tumour-specific CTLs and thereby 
promote tumour growth (Chen et al., 2005). In fact, Treg cell function is a major obstacle in the 
immunotherapeutic treatment of malignant melanoma (Gajewski, 2006). For this reason, 
murine melanoma models can not only be used as a tool to assess CTL and Treg cell function 
in vivo, but also to investigate the balance between pro- and anti-inflammatory aspects of an 
immune response. 
 
1.4 Aim of the thesis 
The Hh signalling pathway is one of the most fundamental signal transduction pathways in 
embryonic development and also responsible for the homeostasis of many adult structures in 
both invertebrates and vertebrates. Many lines of evidence strongly suggest that this 
pathway is implicated in haematopoiesis and lymphopoiesis as well but its precise role in this 
context remains elusive due to conflicting data reported by different groups. The aim of this 
study was to gain further insights into the implication of Hh signalling in the development and 
function of T lymphocytes, a central component of the adaptive immune system. For this 
purpose, a mouse model was employed which is characterised by a T cell-specific 
inactivation of the Hh receptor Ptch. This was expected to constitutively activate the 
canonical signalling cascade and thus influence cell behaviour. In order to study potential 
effects of the Ptch ablation on the development and function of T cells, a comprehensive set 
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of experimental approaches was employed which focussed on various aspects of T cell 
development and function both in vitro and in vivo. 
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2.1.1 General Laboratory equipment 
Instrument Model Manufacturer 
Animal Balance Type 1003 Sartorius, Göttingen, 
Germany 
Animal Clipper Moser AnimalLine ARCO 
Type 1856 
Harotec, Berlin, Germany 
Blood glucose meter Ascensia CONTOUR Bayer, Leverkusen, 
Germany 
Calliper Digital Calliper 0-150mm Carl Roth, Karlsruhe, 
Germany 
Cameras Colorview Olympus, Tokio, Japan 
 Lumix DMC-TZ3 Panasonic, Osaka, Japan 




 Labofuge 400R 
Multifuge 4KR 
Heraeus, Hanau, Germany 
 Type 2-5 Sigma Laborzentrifugen 
GmbH, Osterode am Harz, 
Germany  







EPS 301 Amersham Biosciences, 
Freiburg, Germany 
FACS FACSCanto II BD Biosciences, Heidelberg, 
Germany 
Flattening table for clinical 
histopathology 
HI1220 Leica Biosystems, Wetzlar, 
Germany 
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Gel documentation system UV Transilluminator and 
Camera system 
Intas Science Imaging 
Instruments, Göttingen, 
Germany 
Harvester MicroBeta FilterMate-96 Perkin Elmer, Rodgau, 
Germany 
Incubator HERAcell 150 
HERAcell 240 
Heraeus, Hanau, Germany 
Infrared Lamp Balance 100W Philips, Amsterdam, 
Netherlands 
Laboratory Balance TE313S Sartorius, Göttingen, 
Germany 
Laminar Airflow Workbench HERAguard 
HERAsafe 
Heraeus, Hanau, Germany 









PowerWave 340 BioTek Instruments, Bad 
Friedrichshall, Germany 
Microscopes Televal 31 
Primostar 
Carl Zeiss, Oberkochen, 
Germany 
 Olympus BX51 Olympus, Tokio, Japan 
Microwave oven R-212 Sharp, Osaka, Japan 
Paraffin stretching bath Type 25900 Medax, Kiel, Germany 
PCR Cycler Mastercycler EP Gradient Eppendorf, Hamburg, 
Germany 
pH-Meter 766 Calimatic Knick, Berlin, Germany 
Photometer BioPhotometer Eppendorf, Hamburg, 
Germany 






 Transferpette S-12 Brand, Wertheim, Germany 
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Pipetting aid Accu-Jet pro Brand, Wertheim, Germany 
 Easypet Eppendorf, Hamburg, 
Germany 
Radiation System RS255 X-Ray Research 
System 
Gulmay Medical Systems, 
Surry, UK 
Real Time PCR 7500 Real Time PCR 
System 
Applied Biosystems, Foster 
City, CA, USA 
Reciprocating Sample 
Shaker 
GFL-3006 Gesellschaft für 
Labortechnik, Burgwedel, 
Germany 
Rectal Probes for Rodent 
Thermometer 
BIO-BRET-3 Bioseb, Vitrolles, France 
Refrigerators various Liebherr, Bulle,  
Switzerland 
Rodent Thermometer TK9882 Bioseb, Vitrolles,  
France 
Scintillation Counter MicroBeta² Plate Counter Perkin Elmer, Rodgau, 
Germany 
Sliding Microtome SM2000R Leica Biosystems, Wetzlar, 
Germany 
Thermomixer Thermomixer comfort Eppendorf, Hamburg, 
Germany 
Tissue Embedding Center EG1160 Leica Biosystems, Wetzlar, 
Germany 
Tissue Processor  TP1020 Leica Biosystems, Wetzlar, 
Germany 
Vortexer Vortex Genie2 Bender & Hobein, Zürich, 
Switzerland 
Water bath Type W12 Störk-Tronic, Stuttgart, 
Germany 
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2.1.2 Consumables 
Item Type Manufacturer 
Biopsy Pads Q-Path black foam pad Labonord, Templemars, 
France 
Cell culture dishes Tissue / Suspension Culture 
Dish 5 / 10 cm 
Greiner Bio-One, 
Frickenhausen, Germany 
Cell culture flasks Cellstar 175 cm² Greiner Bio-One, 
Frickenhausen, Germany 
Cell culture plates Cellstar Suspension Culture 








Cell strainer Cell strainer 40µm  BD Biosciences, Heidelberg, 
Germany 
 Celltrics 50 µm Partec, Münster, Germany 




 Cover Glasses 24 x 60 mm Th. Geyer, Renningen, 
Germany 
Cover sheets for qRT-PCR MicroAmp Optical Adhesive 
Film 
Applied Biosystems, Foster 
City, CA, USA 
Cuvettes UVette 200-1600 nm Eppendorf, Hamburg, 
Germany 
ELISA plates Nunc Maxisorp flat-bottom 
96 well plates 
eBioscience, San Diego, CA, 
USA 
FACS tubes 5 ml polystyrene round- 
bottom tubes 
BD Biosciences, Heidelberg, 
Germany 
Glass ware various Schott, Mainz, Germany 
Glassfibre filters Filtermat A Perkin Elmer, Rodgau, 
Germany 
Haemocytometer Acc. to Neubauer HBG Henneberg-Sander, 
Giessen-Lützelinden, 
Germany 
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I.V. Catheter Venflon Pro 22G x 25 mm BD Biosciences, Heidelberg, 
Germany 
MACS Columns LS Separation Columns 
autoMACS Columns 
 
Miltenyi Biotech, Bergisch 
Gladbach, Germany 
Microscope slides SuperFrost Plus Menzel-Gläser, 
Braunschweig, Germany 
Needles BD Microlance 3 0,4x19 mm 
BD Microlance 3 0,5x16 mm 
BD Biosciences, Heidelberg, 
Germany 
 Sterican 0,45x12 mm 
Sterican 0,55x25 mm 
B. Braun, Melsungen, 
Germany 
PCR reaction tubes Multiply-µStrip Pro 8-strip Sarstedt, Nümbrecht, 
Germany 
Pipette tips Ultratip 1000 µl  
Ultratip 200 µl 
Greiner Bio-One, 
Frickenhausen, Germany 
 Pipette tip 10 µl Sarstedt, Nümbrecht, 
Germany 
Reaction plates for qRT-PCR 96-well Optical reaction plate Applied Biosystems, Foster 
City, CA, USA 
Reaction tubes Cellstar 50 ml PP 
Cellstar 15 ml PP 
Reaction tube 2 / 1,5 / 0,5 ml 
Greiner Bio-One, 
Frickenhausen, Germany 
Serological pipettes Cellstar 5 / 10 / 25 ml Greiner Bio-One, 
Frickenhausen, Germany 
Solid Scintillator MeltiLex Perkin Elmer, Rodgau, 
Germany 
Syringes Discardit II 2 ml 
Discardit II 5 ml 
BD Biosciences, Heidelberg, 
Germany 
 Soft-Ject 1 ml Tuberkulin Henke-Sass Wolf, Tuttlingen, 
Germany 
 Omnican 40 1 ml B. Braun, Melsungen, 
Germany 
Syringe filters Filtropur S 0,2 µl 
Filtropur S 0,45 µl 
Sarstedt, Nümbrecht, 
Germany 
Tissue cassettes MacrOfFlow Microm International, 
Walldorf, Germany 
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2.1.3 Chemicals and Reagents 
Name Manufacturer 
2'-deoxythymidine triphosphate [3H] Hartmann Analytic, Braunschweig, Germany 
2-Propanol Rotipuran p.a. Carl Roth, Karlsruhe, Germany 
7-Aminoactinomycin D BD Biosciences, Heidelberg, Germany 
Acetic acid glacial Rotipuran 100% p.a. Carl Roth, Karlsruhe, Germany 
Albumin from chicken egg white, Grade V Sigma-Aldrich, Taufkirchen, Germany 
Allhydrogel 2% VacciGrade Sigma-Aldrich, Taufkirchen, Germany 
Ammonium chloride p.a. Merck, Darmstadt, Germany 
Bovine Serum Albumin PAA Laboratories, Pasching, Austria 
Citric acid monohydrate p.a. Merck, Darmstadt, Germany 
Concanavalin A Sigma-Aldrich, Taufkirchen, Germany 
Dexamethasone, water soluble Sigma-Aldrich, Taufkirchen, Germany 
Dimethyl sulfoxide ≥99,8 % Rotipuran p.a. Carl Roth, Karlsruhe, Germany 
Di-sodium hydrogen phosphate 
Dodecahydrate ≥99% p.a. 
Carl Roth, Karlsruhe, Germany 
Entellan new Merck, Darmstadt, Germany 
Eosin (yellowish) Merck, Darmstadt, Germany 
Ethanol ≥99,8% p.a.  Carl Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid tetrasodium 
salt hydrate ≥95% p.a. 
Sigma-Aldrich, Taufkirchen, Germany 
Ethidium bromide solution 1% Carl Roth, Karlsruhe, Germany 
Fetal Bovine Serum Invitrogen, Carlsbad, CA, USA 
Freunds Adjuvant Complete Sigma-Aldrich, Taufkirchen, Germany 
GeneRuler 1kb DNA ladder Fermentas, St. Leon-Rot, Germany 
Hem Alum solution acid acc. to Mayer Carl Roth, Karlsruhe, Germany 
Hydrogen peroxide 30% Rotipuran p.a. Carl Roth, Karlsruhe, Germany 
Ketamin 10% MediStar, Ascheberg, Germany 
Monopotassium phosphate p.a. Merck, Darmstadt, Germany 
Neomycin trisulfate salt hydrate p.a. Sigma-Aldrich, Taufkirchen, Germany 
Orange G Sigma-Aldrich, Taufkirchen, Germany 
Paraffin wax for histology Sigma-Aldrich, Taufkirchen, Germany 
PCR dNTP Mix Genaxxon Bioscience, Ulm, Germany 
Penicillin / Streptomycin Invitrogen, Carlsbad, CA, USA 
Potassium chloride p.a. Merck, Darmstadt, Germany 
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Potassium dihydrogen phosphate p.a. Merck, Darmstadt, Germany 
Potassium hydrogen carbonate p.a. Merck, Darmstadt, Germany 
Protein G Plus Agarose Santa Cruz Biotechnology, Heidelberg, 
Germany 
Rompun 2% Bayer, Leverkusen, Germany 
Roti Histofix 4% Carl Roth, Karlsruhe, Germany 
Sevorane Abbott, Wiesbaden, Germany 
Sodium azide p.a. Sigma-Aldrich, Taufkirchen, Germany 
Sodium carbonate p.a. Merck, Darmstadt, Germany 
Sodium chloride  ≥99,5% p.a.  Carl Roth, Karlsruhe, Germany 
Sodium dodecyl sulphate ≥99% p.a. Carl Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate p.a. Merck, Darmstadt, Germany 
Sulfuric acid 95-98% p.a. Merck, Darmstadt, Germany 
Tetramethylbenzidine 3,3’,5,5’ Sigma-Aldrich, Taufkirchen, Germany 
Tris Pufferan ≥99,9% p.a. Carl Roth, Karlsruhe, Germany 
Trypsin-EDTA 25% Invitrogen, Carlsbad, CA, USA 
Tween 20 Carl Roth, Karlsruhe, Germany 
UltraPure Agarose Invitrogen, Carlsbad, CA, USA 
Xylol (isomers) >98% p.a. Carl Roth, Karlsruhe, Germany 
 
2.1.4 Media, Buffer and Solutions 
 
2.1.4.1 Media 
RPMI / FBS / PS 
 500 ml RPMI Medium 1640 + GlutaMAX (Invitrogen, Carlsbad, CA, USA) 
 10% FBS 
 100 U / ml  Penicillin 
100 µg / ml  Streptomycin 
 
DMEM / FBS / PS 
 500 ml DMEM + GlutaMAX (Invitrogen, Carlsbad, CA, USA) 
 10% FBS 
 100 U / ml  Penicillin 
100 µg / ml  Streptomycin 
 
MATERIAL AND METHODS 
 31 
L Cell Conditioned Medium (LCCM) 
Supernatant of cultivated L292 cell line, see section 2.2.2.1.5.1. 
 
2.1.4.2 Buffers and solutions 
Cell dissociation buffer, enzyme-free 
Invitrogen, Carlsbad, CA, USA 
 
PBS 
 1000 ml H2O 
 80 g NaCl 
 29 g Na2HPO4 x 12H2O 
 2 g KCl 
 2 g KH2PO4
 
 pH  7,2 – 7,3  
 
PBS / BSA 
 1000 ml PBS 
 1 % BSA 
  
PBS / Tween 
 1000 ml PBS 
 0,1 % Tween 20 
 
MACS Buffer 
 1000 ml PBS 
 0,5 % BSA 
 2 mM EDTA 
 
MACS Rinse Buffer 
 1000 ml PBS 
 2 mM EDTA 
 
FACS Buffer 
 1000 ml PBS 
 0,1 % BSA 
 0,01 % NaN3 
 
Erythrocyte Lysis  Buffer 
 1000 ml  di H2O 
 168 mM NH4Cl 
 10 mM KHCO3 
 0,1 mM EDTA 
 
TAC Buffer 
 1000 ml  di H2O 
 155 mM NH4Cl 
 20 mM Tris 
 pH 7,2 
 
Tail Buffer 
 1000 ml  di H2O 
 1 % SDS 
 100 mM NaCl 
 100 mM EDTA 
 5 mM Tris 
 
TE Buffer 
 1000 ml  di H2O 
 10 mM Tris 
 1 mM EDTA 
 pH 8,0 
 
TAE Buffer 
 1000 ml di H2O 
 4,8 g Tris 
 1,1 g Acetic acid glacial 
 0,29 g EDTA 
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Sodium Carbonate Coating Buffer 
 1000 ml di H2O 
 7,13 g NaHCO3 
 1,59 g Na2CO3 
 pH 9,5 
 
Substrate Buffer (ELISA) 
 1000 ml di H2O 
 21 g citric acid 
 71,7 g Na2HPO4 x 12H2O 
 
 
Substrate Solution (ELISA) 
 10 ml Substrate Buffer 
 1 mg TMB 
 100 µl DMSO 









Taq-Polymerase with Buffer S Genaxxon Bioscience, Ulm, Germany 
Proteinase K Applichem, Darmstadt, Germany 
 
2.1.6 Antibodies for flow cytometry, cell separation and stimulation 
Specificity Clone Isotype Conjugation Application Manufacturer 
CD3 17A2 Rat 
IgG2b,  
PerCP/Cy5.5 FACS BioLegend 
CD3  145-2C11 Hamster 
IgG1,  




CD3  145-2C11 Hamster 
IgG1,  
- In vitro 
stimulation 
BioLegend 
CD4 RM4-5 Rat 
IgG2a,  
PerCP FACS BD 
Biosciences 
CD4 RM4-5 Rat 
IgG2a,  
APC FACS BD 
Biosciences 
CD8  53-6.7 Rat 
IgG2a,  
PE FACS BD 
Biosciences 
CD8  53-6.7 Rat 
IgG2a,  
PE-Cy7 FACS eBioscience 
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CD11b M1/70 Rat 
IgG2b,  






- FACS BD 
Biosciences 
CD25 PC61 Rat 
IgG1,  
APC-Cy7 FACS BD 
Biosciences 
CD28 37.51 Hamster 
IgG2, 1 




CD28 37.51 Hamster 
IgG2, 1 
- In vitro 
stimulation 
BioLegend 
CD44 IM7 Rat 
IgG2b,  






PE FACS BD 
Biosciences 
CD69 H1.2F3 Hamster 
IgG1, 3 
Biotin FACS BD 
Biosciences 






TCR H57-597 Hamster 
IgG2a, 1 
FITC FACS BD 
Biosciences 
Biotin - (Streptavidin) APC-Cy7 FACS BD 
Biosciences 
F4/80 CI:A3-1 Rat 
IgG2b 
FITC FACS BioLegend 
FoxP3 FJK-16S Rat 
IgG2a,  
APC  FACS eBioscience 
GITR DTA-1 Rat 
IgG2b,  
PE-Cy7 FACS BD 
Biosciences 
Ly-6G/-6C RB6-8C5 Rat 
IgG2b,  
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Siglec-F E50-2440 Rat 
IgG2a,  
PE FACS BD 
Biosciences 
 
Note: Antibodies which were part of commercially available assay are not included in this list. 
 
Manufacturer Information:  BD Biosciences Heidelberg, Germany 
     BioLegend  San Diego, CA, USA 
eBioscience  San Diego, CA, USA 
Southern Biotech Birmingham, AL, USA 
 
2.1.7 Commercial Assays 
Name Manufacturer 
CD4+ CD25+ Regulatory T Cell Isolation Kit, Mouse Miltenyi Biotech, Bergisch 
Gladbach, Germany 
Foxp3 / Transcription Factor Staining Buffer Set eBioscience, San Diego, CA, USA 
iScript cDNA Synthesis Kit Bio-Rad Laboratories, München, 
Germany 
Mouse IFN-  ELISA MAX Standard BioLegend, San Diego, CA, USA 
Mouse IL-2 ELISA MAX Standard BioLegend, San Diego, CA, USA 
OptEIA Mouse IFN-  ELISA Set BD Biosciences, Heidelberg, 
Germany 
OptEIA Mouse IL-2 ELISA Set BD Biosciences, Heidelberg, 
Germany 
Pan T Cell Isolation Kit II, Mouse Miltenyi Biotech, Bergisch 
Gladbach, Germany 
Power SYBR Green PCR Master Mix Applied Biosystems, Foster City, 
CA, USA 
Quick-RNA MiniPrep  Zymo Research, Irvine, CA, USA 
 
2.1.8 Oligonucleotides 
All oligonucleotides were purchased from Metabion, Martinsried, Germany or Qiagen, Hilden, 
Germany. 
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2.1.8.1 Oligonucleotides for genotyping 
A - Transcript, B - Name, C - Sequence, D - Melting temperature, E - Amplicon size, F - Reference 




TGGTAATTCTGGGCTCCCGT 61 °C 
445 bp 
Uhmann et al., 








TGGTAATTCTGGGCTCCCGT 61 °C 
150 bp 
Uhmann et al., 








CCAGGCTAAGTGCCTTCTCTACA 62 °C 
500 bp 
Uhmann et al., 
2011 GT1 
Rev 
AATGCTTCTGTCCGTTTGCCGGT 66 °C 
 
2.1.8.2 Oligonucleotides for qRT-PCR 
A - Transcript, B - Name, C - Sequence, D - Melting temperature, E - Amplicon size, F - Reference 
A B C D E F 
Ptch wt 
mPtch11 AAAGCCGAAGTTGGCCATGGGTAC 66 °C 
263 bp 
Uhmann  
et al., 2011 
mPtch-tq-
Ex8R 
TGCTTGGGAGTCATTAACTGGA 59 °C 
Ptch del 
mPtch11 AAAGCCGAAGTTGGCCATGGGTAC 66 °C 
237 bp 
Uhmann  
et al., 2011 
mPtch-tq-
Ex7/10R2 
TTAAACAGGCATAGGCAAGCTGAC 62 °C 
Ptch2 
mPtch2-F TCCAAGTATCACTCTATGGGAAATC 60 °C 
116 bp This work 
mPtch2-R TTCTCAATCATCCGCTCGAT 61 °C 
Gli1 
mGli1-tq-F TACATGCTGGTGGTGCACATG 61 °C 
115 bp 
Nitzki  




GGTCATCTACGAGACCAACTGC 61 °C 
272 bp 
Uhmann  
et al., 2011 Gli2-RT-
PCR-R 
GTGTCTTCAGGTTCTCCAGGC 61 °C 
HPRT1 





HPRT1-R GGGACGCAGCAACTGACATT 61 °C 
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2.1.9 Cell lines 
L292 
L929 is a murine aneuploid fibrosarcoma cell line (Earle et al., 1943) which is frequently used 
as a source for macrophage colony-stimulating factor (M-CSF), a cytokine that promotes the 
differentiation of haematopoietic stem cells into macrophages (Ladner et al., 1988). The cell 
line was kindly provided by Prof. Dr. Jan Tuckermann from the Institute of General Zoology 
and Endocrinology at Ulm University, Ulm, Germany. 
 
B16F10 
B16F10 (Fidler, 1973) is a melanoma cell line of B6 mouse origin which developed 
spontaneously and has been used extensively as a highly aggressive model for murine 
tumour immunotherapy studies (Wang et al., 1998). Cells were a kind gift from Prof. Dr. 




An inbred strain with a characteristic black fur colour. Mice were obtained from Charles River 
Laboratories, Wilmington, USA. 
 
BALB/c  
An inbred strain with a characteristic white fur colour. Mice were obtained from Charles River 
Laboratories, Wilmington, USA. 
 
CD4Cre+/- Ptchflox/flox 
CD4Cre+/- Ptchflox/flox mice were kindly provided by Prof. Dr. Heidi Hahn from the Institute of 
Human Genetics in Göttingen. They were generated by crossing Ptchflox/flox mice (Uhmann et 
al., 2007) with CD4Cre transgenic mice that express the P1 bacteriophage-derived Cre 
recombinase under the control of the CD4 promoter (Wolfer et al., 2001). Expression of the 
Cre recombinase starts from DN3 stage of thymocyte development and catalyses the 
excision of exons 8 and 9 of Ptchflox alleles which additionally leads to a frame-shift in the 
following exons 10-23. This results in the generation of transcripts that cannot be translated 
into functional proteins. While mice with a mixed C57BL/6 and BALB/c genetic background 
were used for some in vitro investigations, most in vitro and all in vivo experiments were 
performed with mice that had been backcrossed to the C57BL/6 background for more than 
10 generations. 




4D v12 4D, Eching, Germany 
Adobe Photoshop CS v8.01 Adobe Systems, San Jose, CA, USA 
analySISB Olympus, Tokio, Japan 
BD FACSDiva Software v6.1.2 BD Biosciences, Heidelberg, Germany 
Gen5 v1.09.8 BioTek Instruments, Bad Friedrichshall, Germany 
GraphPad Prism v5.04 GraphPad Software, La Jolla, CA, USA 
Intas GDS Intas, Göttingen, Germany 
MicroBeta² Windows Workstation v1.0 Perkin Elmer, Rodgau, Germany 
MS Office 2003 SP3 Microsoft, Redmond, WA, USA 




2.2.1 General animal work 
 
2.2.1.1 Mouse husbandry 
Mice were kept alone or in groups either in Makrolon cages type II and III (Tecniplast, 
Hohenpreißenberg, Germany) at the Institute of Human Genetics or under specific pathogen 
free (SPF) conditions in individually ventilated cages (IVC) at the European Neuroscience 
Institute (both part of the University Medical Center Göttingen, Göttingen, Germany). A 
12 hour day/night cycle and constant temperature and humidity levels were maintained 
throughout breeding and experiments. Animals were provided with a standard laboratory 
rodent diet and drinking water ad libitum. All animal experiments were conducted in 
accordance with the ethical standards of humane animal care and approved by the 
appropriate authorities in Lower Saxony (LAVES). 
 
2.2.1.2 Identification and genotyping of CD4Cre+/- Ptchflox/flox mice 
Identification of individual animals was achieved using ear markings which were applied four 
weeks after birth. Tail biopsies were collected at the same time point and stored at -20 °C 
before they were used for genotyping. Therefore, genomic DNA was isolated from biopsies 
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and used for a polymerase chain reaction (PCR)-based characterisation with previously 
described primer combinations. (Uhmann et al., 2007; Zibat et al., 2009; Uhmann et al., 
2011).  
 
2.2.1.3 Tissue preparation and isolation of cells 
 
2.2.1.3.1 Lymphocytes 
Lymphocytes were either isolated from the spleen or from lymph nodes (nodi lymphoidei 
cervicales, nodi lymphoidei axillares, nodi lymphoidei inguinales, nodi lymphoidei 
mesenterici). Mice were sacrificed by cervical dislocation, the tissue was extracted and 
placed in a small petri dish with PBS / BSA. Tissue forceps were employed for mechanical 
breakup of the tissue and the emerging cell suspension was passed through a 40 µm cell 
strainer to remove cell clusters. The cells were then washed in PBS / BSA and centrifuged at 
330 x g for 6 minutes.  
 
2.2.1.3.2 Thymocytes 
For isolation of thymocytes, mice were sacrificed in a carbon dioxide atmosphere and the 
thymi were extracted. Mechanical breakup and generation of a single cell suspension was 
achieved as described before. 
 
2.2.1.3.3 Bone Marrow 
Mice were sacrificed by cervical dislocation, hind limbs were dissected and femurs and tibiae 
cleaned from remaining tissue. Both ends were opened up with a scissor and the BM was 
flushed out with cold PBS / BSA using a syringe with a needle of the appropriate size. The 
BM was then resuspended several times to produce a homogenous cell suspension which 
was additionally passed through a 40 µl nylon strainer. Finally, the cells were washed in PBS 
/ BSA and centrifuged at 330 x g for 6 minutes. 




2.2.1.4.1 Short-term anaesthesia 
For intranasal application of dissolved Ova, mice were lightly anaesthetised with sevoflurane 
(Sevorane). Induction and recovery from this inhalation anaesthesia proceeded quickly while 
mice remained unconscious for approximately 10 seconds. 
 
2.2.1.4.2 Extended anaesthesia 
An extended anaesthesia was used for fur removal prior to tumour induction and for the 
subcutaneous application of B16F10 melanoma cells itself. To this end, 10 µl of sterile PBS 
with 1% ketamin hydrochloride (Ketamin) and 0,4 ‰ xylazin hydrochloride (Rompun) were 
administered intraperitoneally per gram of body weight. Induction of anaesthesia occurred 
after 2-3 minutes and lasted for approximately 60 minutes. Mice were kept warm during 
anaesthesia to prevent hypothermia. 
 
2.2.1.5 Irradiation 
Mice were placed in an individually manufactured plastic box and irradiated with a RS 225 
X-Ray Research System which was operated at 150 kV, 15 mA and with a 0,5 mm Cu 
filtration. A radiation dose of 1 Gy / min was given for a time of 8,5 minutes which resulted in 
a total radiation of 8,5 Gy. 
 
2.2.2 In vitro methods 
 
2.2.2.1 Cell culture 
Manipulation of cells was always performed under sterile conditions using a laminar airflow 
workbench and sterile equipment. Unless stated otherwise, cells were centrifuged at 330 x g 
and 4°C for 6 minutes and incubated at 37°C under a humidified atmosphere of 5% CO2.  
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2.2.2.1.1 Cell counting 
Cell numbers were determined using a counting chamber according to Neubauer. With 
respect to the expected cell number, the cell suspension was diluted to a concentration of 
approximately 106 cells / ml and a minimum of 2 opposing quadrants were counted. 
Erythrocytes and apoptotic cells were morphologically identified and excluded. The total cell 
number was calculated according to the following formula: Average cells per quadrant x 104 x 
dilution x total volume. 
 
2.2.2.1.2 Haemolysis 
Removal of erythrocytes from isolated lymphocytes or thymocytes was achieved using 
erythrocyte lysis buffer or TAC buffer. If erythrocyte lysis buffer was used, cells were 
resuspended in 2 ml PBS, 5 ml buffer were added and the suspension was incubated for 5 
minutes on ice. The reaction was stopped by adding 43 ml PBS / BSA and the cells were 
centrifuged. TAC buffer was exclusively employed to remove erythrocytes from total 
splenocytes which were used for ex vivo restimulation in allergic airway inflammation 
experiments. Here, cells were resuspended in 1 ml PBS and 6 ml TAC buffer were added 
before the cells were incubated for 12 min on ice. The reaction was also stopped by adding 
43 ml PBS / BSA and the cells were centrifuged. 
 
2.2.2.1.3 Thawing of cryopreserved cells 
Cell aliquots which had been stored at -150°C were rapidly thawed at 37°C in a water bath 
and poured into a 50 ml reaction tube containing prewarmed medium and FBS at a ratio of 
1:1. The cells were then centrifuged at 330 x g and room temperature for 6 minutes before 
the supernatant was discarded. Cells were subsequently resuspended in prewarmed 
medium and placed in an incubator. 
 
2.2.2.1.4 Detachment of adherent cells 
In vitro differentiated macrophages were placed on ice for 15 minutes to induce retraction of 
cell protrusions. After that, the medium was removed and replaced with 1 ml cell dissociation 
buffer before the cells were incubated for another 5 minutes at 37°C in an incubator. Cells 
were then detached by rinsing with PBS, collected in a 50 ml reaction tube and washed with 
PBS / BSA. For detaching B16F10 melanoma and L929 cells, the medium was removed and 
the cells were washed twice with PBS. Depending on the size of the petri dish or culture 
flask, between 1 and 5 ml Trypsin-EDTA were added and the cells were incubated at 37°C 
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for 2-4 minutes. The dissociation process was frequently controlled under the microscope 
and stopped when the cells were almost completely detached by adding a large volume of 
PBS / BSA. Remaining adherent cells were rinsed off and the suspension was transferred to 
a 50 ml reaction tube and washed with PBS / BSA. 
 
2.2.2.1.5 Generation of bone marrow-derived macrophages 
 
2.2.2.1.5.1 Preparation of L cell conditioned medium 
LCCM was used a source for M-CSF to promote the differentiation of HSCs into 
macrophages. L929 cells were thawed as described, resuspended in DMEM / FBS / PS and 
placed in a 10 cm petri dish which was incubated at 37°C and 5% CO2 until the cell were 
grown to confluence. Cells were detached and washed, resuspended in fresh medium and 
split onto five 10 cm petri dishes. After the cells had grown to confluence again they were 
detached, washed and transferred with 40 ml of fresh medium into 175 cm² cell culture 
flasks. The conditioned medium was collected every other day, immediately frozen at -20°C 
and replaced with fresh medium. This procedure was repeated another three times before 
the cells were discarded. Prior to usage, the medium was thawed and diluted at a ratio of 1:4 
with DMEM / FBS / PS. 
 
2.2.2.1.5.2 In vitro differentiation of macrophages 
A BM suspension was prepared from femurs and tibiae as described. Cells were washed in 
PBS / BSA, resuspended in 10 ml LCCM and transferred into a 175cm² cell culture flask in 
which they were incubated over night. On the following day, non-adherent cells were 
separated from adherent fibroblasts and stroma cells by soft rinsing. The medium containing 
the HSCs was split onto two 10 cm suspension culture petri dishes and 5 ml of fresh LCCM 
were added to each plate. After four days of incubation, an additional 5 ml LCCM were 
added and the cells were incubated for another 2-4 days. The differentiation process was 
controlled daily with a microscope and evaluated according to the cell’s morphological 
changes. Finally, the cells were detached as described and tested by FACS with antibodies 
against F4/80 and CD11B in conjunction with a 7-Aminoactinomycin D (7-AAD) staining to 
identify apoptotic cells. On average, the cell viability was greater than 90% while more than 
99% showed a high expression of both surface markers. 
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2.2.2.1.6 Cultivation of B16F10 melanoma cells 
The mouse melanoma cell line B16F10 was cultured in RPMI / FCS / PS and taken into 
culture 3 days before usage. Cells of an identical passage number were used for all 
experiments. 
 
2.2.2.2 Cell purification and depletion 
Magnetic purification or depletion of cells was achieved using the autoMACS separator. The 
device was operated according to the manufacturer’s instructions. 
 
2.2.2.2.1 Isolation of conventional T cells 
Conventional T cells were negatively isolated using the Miltenyi Pan T Cell Isolation Kit II. 
Spleens with or without lymph nodes were dissected, a homogenous single cell suspension 
was generated and the cells were counted as described. The cells were then washed and 
resuspended in 4 µl MACS buffer plus 1 µl biotin-antibody cocktail per 106 cells. After an 
incubation period of 10 minutes at 4°C, another 3 µl buffer and 2 µl anti-biotin microbeads 
were added per 106 cells. The suspension was mixed and incubated again at 4°C for 15 
minutes. Finally the cells were washed in 30 ml MACS buffer, passed through a 50 µl cell 
strainer and resuspended in a maximum volume of 2 x 109 cells per ml in MACS buffer 
before they were placed in the autoMACS separator and separated using the DEPLETE-
Program. After separation, the cells were washed in PBS / BSA, counted and a sample was 
collected for FACS analysis. The average yield was 12-18% of nucleated cells with a purity 
of approximately 93% cells as defined by TCR expression. 
 
2.2.2.2.2 Isolation of regulatory T cells 
Treg
 cells were isolated using the Miltenyi CD4+ CD25+ Regulatory T Cell Isolation Kit. 
Spleens were dissected, a single cell suspension was generated and the cells were washed 
and counted as described. For 106 cells, 4 µl MACS buffer and 1 µl biotin-antibody cocktail 
were added to the cells which were then incubated for 10 minutes at 4°C. Afterwards, 3 µl 
MACS buffer were added together with 2 µl anti-biotin microbeads and 1 µl anti-CD25-PE per 
106 cells. The suspension was mixed and incubated at 4°C for another 15 minutes. Cells 
were washed in 30 ml MACS buffer, passed through a 50 µl cell strainer and resuspended in 
a maximum volume of 2 x 109 cells per ml in MACS buffer. Negative isolation of CD4+ T cells 
was achieved using the DEPL025 program of the autoMACS separator. Cells were washed 
after the separation, counted and resuspended in 9 µl MACS buffer and 1 µl anti-PE 
MATERIAL AND METHODS 
 43 
microbeads per 106 cells. After a 15 minute incubation period at 4°C the cells were washed 
again with 30 ml MACS buffer and passed through a 50 µl cell strainer. CD4+ CD25+ DP and 
CD4+ CD25- SP cells were finally separated using the POSSELD2 program of the autoMACS 
device. On average, the yield for CD4+ CD25+ cells was 2% of total cells with a purity of 
>95% as revealed by FACS analysis. Further discrimination between Treg cells and activated 
conventional Th cells within the CD4
+ CD25+ population was achieved by an additional 
staining against FoxP3 and glucocorticoid induced tumour necrosis factor receptor family 
related gene (GITR). This revealed that on average >85% of isolated CD4+ CD25+ cells were 
bona fide Treg cells.  
 
2.2.2.2.3 Generation of T cell depleted bone marrow 
T cells were removed from total BM using CD90.2 microbeads (Miltenyi) in aGvHD 
experiments. For this purpose, a single cell suspension was generated from BM as 
described. Cells were resuspended in 9 µl MACS buffer plus 0,6 µl anti-CD90.2 microbeads 
per 106 cells and incubated at 4°C for 20 minutes. After a washing step with 10 ml MACS 
buffer, the cells were passed through a 50 µl cell strainer and resuspended in a maximum 
volume of 2 x 109 cells per ml in MACS buffer. Depletion of CD90.2 positive cells was 
accomplished with the DELPLETES program of the autoMACS separator. Successful depletion 
of T cells from the BM was verified by FACS with a staining against the TCR -chain. 
Percentage of residual T cells among BM cells was routinely well below 1%. 
 
2.2.2.3 Proliferation assays 
 
2.2.2.3.1 Allogenic stimulation of T cells 
Allogenic stimulation of Ptch-deficient and wild type T cells was performed in the setting of a 
mixed leukocyte reaction (MLR). T cells were isolated from CD4Cre+/- Ptchflox/flox and 
Ptchflox/flox mice (C57/BL6 background) while macrophages were generated from the BM of 
BALB/c mice as described. 105 T cells were cocultured with an equal amount of BM derived 
macrophages (BMDM) in a total volume of 200 µl RPMI / FBS / PS in 96-well round-bottom 
plates. T cells or macrophages alone served as negative controls while T cells activated with 
2,5 µg / ml Concanavalin A (ConA) were used as positive controls. All samples were 
analysed in triplicates to increase the informative value of the data. After a culture period of 
72 hours, 50 µl of supernatant was removed from each well and replaced with fresh medium 
containing tritiated thymidine with an activity of 740 kBq / ml. Supernatants were immediately 
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frozen at -20°C and used later for cytokine analysis. After another incubation of 16 hours, the 
cells were harvested and proliferation was determined by scintillation counting. 
 
2.2.2.3.2 Polyclonal stimulation of T cells 
T cells were isolated from CD4Cre+/- Ptchflox/flox and Ptchflox/flox mice. 105 cells per well were 
seeded in 96-well flat-bottom plates in a total volume of 200 µl RPMI / FBS / PS. Stimulation 
was achieved by the addition of either ConA or soluble antibodies against CD3  and CD28 in 
optimal (2,5 µg / ml and 1,0 µg / ml each) or suboptimal (0,5 µg / ml and 0,01 µg / ml each) 
concentrations, respectively. T cells alone were used as negative controls and all samples 
were analysed in triplicates. After 24, 48 and 72 hours of culture, 50 µl of supernatant were 
removed from each well and replaced with fresh medium containing tritiated thymidine with 
an activity of 740 kBq / ml. The supernatants were immediately frozen at -20°C and used 
later for cytokine analysis while the cells were harvested and proliferation was determined by 
scintillation counting after an additional incubation of 16 hours.  
 
2.2.2.3.3 Suppression assays 
Suppression assays were performed for functional analysis of Treg cells in vitro. Therefore, 
CD4+ CD25+ Treg cells and CD4
+ CD25- Th cells were isolated from CD4Cre
+/- Ptchflox/flox and 
Ptchflox/flox mice. 105 Treg cells were seeded in 96-well round-bottom plates together with Th 
cells at ratios of 1:1, 1:5, 1:10, 1:15 and 1:25 in a total volume of 200 µl RPMI / FBS / PS. 
Polyclonal stimulation was achieved by adding 1 µg / ml soluble anti-CD3  and 5 µg / ml 
anti-CD28 antibodies into the cultures. Treg or Th cells alone as well as stimulated Treg cells 
served as negative controls while stimulated Th cells were used as positive controls. Analysis 
was performed in triplicates for all samples. Supernatants were removed after 48 hours of 
culture, frozen at -20°C and used for later detection of cytokines. 
 
2.2.2.3.4 Ex vivo restimulation of T cells with Ovalbumin 
An ex vivo restimulation of T cells with Ova was performed in allergic airway inflammation 
experiments. For this purpose mice were sacrificed and single cell suspensions were 
generated from the spleens as described. 3 x 105 splenocytes were seeded in 96-well flat-
bottom plates either alone or together with Ova in a concentration of 10 µg / ml in a total 
volume of 200 µl RPMI / FBS / PS. Cells were alternatively activated with 2,5 µg / ml ConA to 
obtain a positive control for cell responsiveness. All samples were analysed in triplicates. 
After an incubation period of 72 hours, 50 µl of supernatant was removed from each well and 
replaced with fresh medium containing tritiated thymidine with an activity of 740 kBq / ml. 
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Supernatants were immediately frozen at -20°C and used later for cytokine analysis. After 
another incubation of 16 hours, the cells were harvested and the proliferation was 
determined by scintillation counting. 
 
2.2.2.3.5 Solid scintillation counting 
Proliferation of T cells in in vitro assays was quantified by the metabolic incorporation of 
tritiated thymidine (3H-TdR) which was detected by solid scintillation counting. After 
incubation with 3H-TdR for 16 hours, the cells were harvested with a MicroBeta Filtermate-96 
Harvester and the labelled DNA was collected onto Filtermat A glassfibre filters. The filters 
were allowed to dry at room temperature for at least 2 hours before the solid scintillator 
(MeltiLex) was melted onto them using a microwave oven. After the scintillator had solidified 
again at room temperature, the filters were placed in counting cassettes and the incorporated 
radioactivity was indirectly measured using a MicroBeta² ß-scintillation counter.  
 
2.2.2.4 Enzyme-linked Immunosorbent Assay 
Enzyme-linked Immunosorbent Assays (ELISAs) were performed to detect cytokines in the 
supernatants of proliferation tests or Ova-specific immunoglobulins in the serum of animals 
during allergic airway inflammation experiments. 
 
2.2.2.4.1 Detection of Cytokines 
Secretion of the cytokines IL-2 and IFN-  was quantified in the supernatant of proliferation- 
and suppression assays using commercially available assays from BD or Biolegend 
according to the manufacturer’s instructions. In brief, the respective capture antibody was 
diluted in an assay-specific coating buffer and incubated over night at 4°C in Nunc MaxiSorp 
96-well plates. On the following day, unbound capture antibody was removed and the wells 
were washed with PBS / Tween. The plates were then blocked with PBS with 10% FBS for 
one hour and washed again. Depending on the analysed cytokine, the samples were diluted 
between 1:2-fold and 1:5-fold before they were incubated together with a standard for two 
hours. In BioLegend assays, the samples were then incubated with a biotinylated detection 
antibody for one hour and with avidin-conjugated horseradish peroxidase (HRP) for another 
30 minutes while both were incubated in parallel for one hour when assays from BD were 
used. Finally, the plates were washed and the substrate solution (see materials) was added 
before the plates were incubated for 5-20 minutes in the dark. The colour reaction was 
stopped with 50 µl 1M H2SO4 and the absorbance at 450 nm and 570 nm was examined with 
a microplate spectrophotometer.  
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2.2.2.4.2 Detection of Ovalbumin-specific Immunoglobulins 
Detection of Ova-specific Immunoglobulins was performed in the serum of mice from allergic 
airway inflammation experiments. Therefore, Nunc MaxiSorp 96-well plates were coated with 
50 µg / ml Ova dissolved in 100 µl sodium carbonate coating buffer per well and incubated at 
4°C over night. On the following day, the plates were washed three times with PBS / Tween 
and subsequently blocked with 100 µl 10% FBS in PBS for one hour at room temperature. 
Serum samples were diluted 1000-fold and split for the detection of IgG and IgE isotypes. 
Samples for IgE detection were incubated with five volume percent Protein G coupled to 
agarose beads for one hour at room temperature on a sample shaker to remove antibodies 
of IgG isotypes. After this incubation, the solution was centrifuged at > 20.000 x g for five 
minutes and only the supernatant was used for IgE detection. The plate was then washed 
three times and, after 100 µl of each sample had been added, sealed and incubated at 4°C 
over night. On the next morning, the plates were washed and 100 µl of a 1:1000 dilution of 
anti-IgG1, anti-IgG2 and anti-IgE antibodies coupled to HRP were added to the samples and 
incubated for one hour at room temperature. After a final washing step, the substrate solution 
was added and plates were incubated for 1-5 minutes in the dark. As described before, the 
colour reaction was stopped with 50 µl 1M H2SO4 and the absorbance at 450 nm and 570 nm 
was examined with a microplate spectrophotometer. 
 
2.2.2.5 Flow cytometry 
 
2.2.2.5.1 Analysis of extracellular antigens 
Approximately 105 cells were transferred into FACS tubes, washed with 3 ml FACS buffer 
and centrifuged at 450 x g and 4°C for 5 minutes. The supernatant was discarded and the 
cells were resuspended in 200 µl FACS buffer. If necessary, the cells were incubated with 
anti-CD16/32 for 10 minutes to block FC receptors and improve the subsequent staining. 
Afterwards, the respective fluorochrome- or biotin-conjugated antibodies were added to the 
cells. Optimal concentrations for individual antibodies were previously defined and ranged 
from dilutions of 200-fold to 2000-fold. The suspension was vortexed and incubated in the 
dark at 4°C for 15 minutes. When biotin-conjugated antibodies were used, the cells were 
washed and incubated again with fluorochrome-coupled streptavidin for another 15 minutes. 
Finally, the cells were washed with 3 ml FACS buffer, resuspended in 200 µl buffer and 
analysed. 
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2.2.2.5.2 Analysis of intracellular antigens 
Intracellular detection of the transcription factor FoxP3 was performed using the FoxP3 / 
Transcription Factor Staining Buffer Set. Initially, staining of surface antigens was conducted 
for 106 cells as described above. The cells were then washed in 2 ml PBS at 450 x g and 4°C 
for 5 minutes and the supernatant was discarded. Fixation and permeabilisation of the cells 
for subsequent intracellular staining was achieved by adding 300 µl Fix / Perm under 
vortexing which was followed by a 30-minute incubation at room temperature. The cells were 
washed in 2 ml PBS and afterwards in 1 ml Perm buffer before a FoxP3-specific antibody 
was added. After another incubation period of 30 minutes, the cells were washed again with 
1 ml Perm buffer and subsequently with 3 ml FACS buffer before they were analysed.  
 
2.2.2.5.3 Apoptosis staining 
Identification of apoptotic cells was achieved by using the fluorescent chemical compound 
7-AAD which was applied in apoptosis assays as well as in most standard stainings. For this 
purpose, 1,5 µl of 7-AAD were added to the cells after the staining of extracellular antigens 
was completed. The suspension was vortexed and incubated at 4°C in the dark for 




2.2.2.6.1 Tissue fixation 
Histological analyses of lung tissue was performed in allergic airway inflammation 
experiments. Mice were sacrificed by cervical dislocation, the lungs were dissected, filled 
with a 4% paraformaldehyde solution (Roti Histofix) and incubated in the same solution at 
room temperature for two days. After this fixation step, the lungs were put into PBS for at 
least 2 hours, cut into small slices of approximately 2-4 mm diameter, embedded in biopsy 
pads and placed in tissue cassettes. These cassettes were again placed in PBS for at least 
one hour before the tissue was sequentially dehydrated through a series of graded ethanol 
baths and infiltrated with paraffin wax utilising a benchtop tissue processor according to the 
following protocol: 
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Step Duration Solution 
Dehydration 60 min 50% EtOH 
60 min 70% EtOH 
2 x 60 min 80% EtOH 
2 x 90 min 96% EtOH 
2 x 90 min 99% EtOH 
2 x 60 min Xylol 
Paraffinisation 2 x 120 min Paraffin 
  
2.2.2.6.2 Preparation and sectioning of paraffin blocks 
After the dehydration process, the tissue biopsies were placed in moulds which were filled 
with molten paraffin and attached to tissue cassettes using a tissue embedding station. The 
wax blocks were separated from the moulds when the paraffin had solidified and sectioned 
using a sliding microtome. For this purpose, the blocks were fixed on the microtome and 
aligned in the vertical plane. Slices were cut with a thickness of 5 µm, stretched in a water 
bath at 40°C and floated onto the surface of microscope slides where they were dried at 
37°C.  
2.2.2.6.3 Hematoxylin and eosin stain 
Once the microscope slides had dried, a hematoxylin and eosin (HE) stain was performed 
according to the following protocol: 
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Step Duration Solution 
Deparaffinisation 2 x 15 min Xylol 
2 x 3 min 99% EtOH 
2 x 3 min 96% EtOH 
2 x 3 min 70% EtOH 
2 x 3 min de-ionized water 
Staining of nuclei 10 min Hem alum solution 
3 min Running tap water 
10 min de-ionized water 
Staining of tissue 5 min 0,1% Eosin Y 
3 min de-ionized water 
Dehydration 2 x 3 min 70% EtOH 
2 x 3 min 96% EtOH 
2 x 3 min 99% EtOH 
2 x 15 min Xylol 
 
In brief, residual paraffin was removed from the tissue with decreasing alcohol 
concentrations. After the samples had been rehydrated, an acidic hemalum solution 
according to Mayer was used to obtain a blue staining of nuclei while yellowish eosin was 
used to colour eosinophilic structures in various shades of pink. Finally, the tissue slices 
were again dehydrated with increasing alcohol concentrations, embedded with Entellan and 
analysed microscopically. 
 
2.2.3 Molecular biological methods 
 
2.2.3.1 Isolation of genomic DNA from biopsies 
Mouse tail biopsies were collected four weeks after birth. They were digested in 750 µl tail 
buffer supplemented with 200 µg Proteinase K at 54°C over night in a thermomixer. On the 
next day, 280 µl of saturated NaCl solution were added to precipitate proteins. The mixture 
was kept at room temperature for 5 minutes before it was centrifuged at > 20.000 x g for 
10 minutes. 850 µl supernatant were transferred into another reaction tube containing 600 µl 
2-propanol to precipitate the genomic DNA. The solution was vortexed and allowed to sit for 
3 minutes at room temperature before it was centrifuged at > 20.000 x g for 10 minutes. After 
the supernatant was discarded, the DNA-containing pellet was washed with 500 µl 70% 
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EtOH and centrifuged again at > 20.000 x g for 5 minutes. Finally, the supernatant was 
completely removed and the DNA dried at 50°C for at least one hour before the pellet was 
resuspended in 100 µl TE buffer. 
 
2.2.3.2 Isolation of total RNA from cells 
Total RNA was prepared from cells with the help of the Quick-RNA MiniPrep kit. Up to 
5 x 106 cells were placed in a 1,5 ml reaction tube and centrifuged at 400 x g and 4°C for 
5 minutes. The supernatant was removed, the pellet resuspended in 600 µl ZR buffer and 
placed on a RNA-binding column. The lysate was centrifuged at > 20.000 x g and 4°C for 
one minute before the flow-through was discarded. After that, the column was washed 
sequentially with 400 µl pre-wash buffer for one minute, then with 700 µl and 400 µl wash 
buffer for 30 seconds each. After a penultimate centrifugation at > 20.000 x g for 2 minutes to 
remove residual wash buffer, the RNA was eluted by adding 50 µl of RNase-free water into a 
1,5 ml reaction tube at > 20.000 x g for 30 seconds. The concentration of the RNA was 
measured and the sample was immediately frozen at -150°C. 
 
2.2.3.3 Measurement of nucleic acid concentration 
Nucleic acid concentrations were determined photometrically. For this purpose, DNA or RNA 
samples were diluted 50-fold in di H2O and placed in photometric cuvettes which were 
analysed with a BioPhotometer.  
 
2.2.3.4 Reverse Transcription 
RNA samples were reverse transcribed employing the iScript cDNA Synthesis Kit for use in 
quantitative reverse transcription polymerase chain reactions (qRT-PCR). To this end, 1 µg 
of RNA was incubated with 0,25 µl Reverse Transcriptase and 4 µl 5x iScript reaction mix in 
a total volume of 20 µl. After a 5-minute incubation at 25°C, the transcription process was 
allowed to proceed at 42°C for another 30 minutes before the reaction was stopped at 85°C 
for 5 minutes. Complementary DNA (cDNA) was stored at -20°C until usage. 
 
2.2.3.5 Polymerase Chain Reaction 
PCR was used for genotyping of CD4Cre+/- Ptchflox/flox mice. For this purpose, 1% of the 
genomic DNA which was extracted from tail biopsies was used. The respective forward and 
reverse oligonucleotides were added in a concentration of 400 nM each together with 5 mM 
PCR dNTP mix, 10% Buffer S and 2 U Thermus aquaticus (Taq) DNA polymerase I. 
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Nuclease-free water was added to a final volume of 25 µl and the PCR was performed 
according to the following three-step protocol using a Mastercycler EP Gradient before the 
products were analysed by agarose gel electrophoresis. 
 
Step Temperature Time  
Initial denaturation 94°C 3 minutes  
Denaturation 94°C 15 seconds 
30 cycles Annealing 64°C 20 seconds 
Elongation 72°C 60 seconds 
Terminal extension 72°C 5 minutes  
 
2.2.3.6 Real Time Quantitative Reverse Transcription PCR 
Quantitative Real Time PCR was used to study the expression of genes that are associated 
with the Hh signalling cascade. Complementary DNA was reverse transcribed from RNA that 
was extracted from purified T cells as described. Approximately 10 ng of cDNA were mixed 
with the appropriate forward and reverse oligonucleotides in a concentration of 300-400 nM 
each together with 12,5 µl Power SYBR Green PCR Master Mix in a total volume of 25 µl. 
The reaction mix was prepared in 96-well Optical Reaction Plates on ice which were sealed 
with MicroAmp Optical Adhesive Film before the reaction was started. PCR was performed 
according to the following two-step protocol on a 7500 Real Time PCR System: 
 
Step Temperature Time  
Preheating 50°C 2 minutes  
Polymerase activation 
& initial denaturation 
95°C 10 minutes  
Denaturation 95°C 15 seconds 
40 cycles 
Annealing & elongation 60°C 60 seconds 
Dissociation stage 
95°C 15 seconds  
60°C 60 seconds  
95°C 15 seconds  
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Analysis was performed using the delta delta cycle threshold ( CT) approximation method. 
In brief, the cycle number at which the transcript of an endogenous control gene reached a 
certain threshold was subtracted from the cycle number at which a specific target gene 
reached the same threshold. From this CT value, the CT value of a calibrator sample was 
subtracted to obtain the CT value. The relative quantitative difference between two 
transcripts was calculated with the formula 2- CT. 
 
2.2.3.7 Agarose Gel Electrophoresis 
PCR products were analysed by agarose gel electrophoresis. Gels containing 2% agarose 
were generated by dissolving the appropriate amount of agarose in TAE buffer in a 
microwave oven. After the agarose had cooled to approximately 60ºC, ethidium bromide was 
added to a final concentration of 1 µg / ml. The agarose was poured into a gel tray with a 
comb and allowed to solidify before it was placed in a gel chamber filled with TAE buffer. 
Samples from PCR were mixed with one fourth of the volume Orange G loading buffer and 
loaded onto the gel. Depending on the size of the chamber, the gels were run at 130-150 V 
until the desired separation was achieved. DNA fragments were visualized by placing the gel 
onto an UV screen (wavelength 302 nm) and photographed. 
 
2.2.4 Disease models 
 
2.2.4.1 Allergic airway inflammation 
For allergic airway inflammation experiments, only female mice between the age of 6 and 12 
weeks were used in experimental groups while control groups were made up of male and 




Mice were initially sensitised against Ova by an intraperitoneal (i.p.) injection of 10 µg Ova 
together with 1,5 mg aluminium hydroxide (Allhydrogel 2%, abbreviated as Alum) as an 
adjuvant and PBS in a total volume of 150 µl. Control animals received Alum and PBS 
without Ova. The emulsions were vortexed for at least 10 minutes and frequently mixed prior 
to injection to assure an evenly distribution of its components. To further enhance the 
immune response, booster injections with the same composition that was used before were 
administered on days 9 and 18 after sensitisation. Finally, antigen challenge was performed 
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four weeks after initial sensitisation and ten days after the final booster injection for both 
immunised and control mice. For this purpose, mice were lightly anaesthetised and received 
an intranasal (i.n.) application of 150 µg Ova dissolved in PBS. This procedure was repeated 
on three consecutive days and followed by a one day resting phase.  
 
2.2.4.1.2 Analysis 
Mice were sacrificed by CO2 inhalation and a midline neck incision was made to cannulate 
the trachea. Lungs were rinsed once with 500 µl cold PBS and the recovered 
bronchoalveolar lavage fluid (BALF) was transferred to a 1,5 ml reaction tube with 200 µl 
FBS. The cells were kept on ice until they were counted and used for FACS analysis while 
the lungs were dissected, fixed and used for histological analysis as described. Cells from 
the BALF were stained with antibodies against CD3, CD4, CD11b, Ly-6G/-6C, F4/80 and 
Siglec F to identify different populations of infiltrating cells. CD4+ T cells were identified as 
CD3+ CD4+ cells with low forward- and side scatter (FSC / SSC) intensity values. 
Macrophages displayed a larger and more granular phenotype and were highly positive for 
the markers F4/80 and CD11b. Eosinophil granulocytes were identified as large and granular 
cells with a high expression of Siglec-F while neutrophils showed intermediate expression of 
this marker in conjunction with a high CD11b and Ly-6G/C expression. Blood was collected 
from mice for serum analysis of Ova-specific immunoglobulins. For this purpose, the vena 
renalis was punctured and the collected blood was centrifuged at > 20.000 x g for 
30 minutes. The serum was removed and stored at -20°C before it was analysed by ELISA 
as described above. Finally, splenocytes were isolated and an ex vivo restimulation assay 
was performed. 
 
2.2.4.2 Acute Graft-versus-Host disease 
For aGvHD experiments, 8-12 week old male BALB/c recipient mice with a minimal weight of 
20 g were used. Groups consisted of at least 6 animals in experimental groups and three 
animals in control groups. 
 
2.2.4.2.1 Induction 
Initially, mice received a total body irradiation of 8,5 Gy. On the following day, T cells were 
isolated from spleens and lymph nodes of CD4Cre+/- Ptchflox/flox and Ptchflox/flox mice and T cell 
depleted BM was generated from C57BL/6 mice as described. 107 T cell depleted BM cells 
were mixed with 2 x 106 T cells and injected in a total volume of 200 µl PBS into the tail vein. 
Control mice received BM without T cells. Starting from one day prior to cell transfer, mice 
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were kept on drinking water supplemented with neomycin at a concentration of 25 µg / ml for 
four weeks. 
 
2.2.4.2.2 Monitoring of disease progression 
Mice were monitored daily during the first ten days after cell transfer and then every other 
day until the experiment ended. They were weighted and their health status was assessed 
according to five clinical parameters which are commonly employed to evaluate GvHD 
severity (Cooke et al., 1996). The relevant parameters are described in the following table: 
 
Parameter Grade 0 Grade 1 Grade 2 
Posture normal Slightly hunched 
when resting 
Severely hunched 
Activity normal Slightly reduced Motionless unless 
stimulated 
Fur ruffling normal Slight ruffling Absent grooming 
and ruffled fur 
Diarrhoea 
 
normal Mild severe 
Weight loss 
 
< 10% 10-25% > 25% 
 
Each parameter received a score from 0 (without symptoms) to 2 (severe symptoms), 
resulting in a total score between 0 and 10. Due to ethical reasons, mice were sacrificed 
when the total clinical score exceeded a value of 7 for more than one day. Additionally, blood 
glucose and body temperature were measured for the first ten days of the experiment. For 
this purpose, the tail vein was punctured and a drop of blood was analysed with a blood 
glucose meter. Body temperature was measured rectally with a rodent thermometer. 
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2.2.4.3 B16 Melanoma model 
Experiments were performed with 2 to 8 month old mice of both genders that were evenly 
distributed among groups. Individual experiments had group sizes of 5 to 8 animals. 
 
2.2.4.3.1 Induction of subcutaneous tumour development 
B16F10 cells were prepared as described, washed twice in PBS to remove residual medium 
and counted. Mice were anaesthetised and the fur on the right flank was removed using an 
animal clipper before 104 B16F10 cells were subcutaneously injected. 
 
2.2.4.3.2 Anti-tumour immunisation 
For some experiments, an anti-tumour immunisation was performed prior to the application 
of melanoma cells. To this end, B16F10 cells were irradiated with 125 Gy and mixed at a 
ratio of two volumes of cell suspension to one volume of Complete Freund’s adjuvant (CFA). 
Cells were injected in a total volume of 150 µl into the left flank of anaesthetised mice. 
Animals were challenged with live B16F10 cells ten days after immunisation. 
 
2.2.4.3.3 Monitoring of disease progression 
Starting from day 7 after challenge, mice were regularly monitored for palpable tumours. 
Tumour size was recorded from two calliper measurements of the longest (a) and shortest 
(b) diameter and the tumour volume was calculated according to the following formula: 
volume = a×b2×0,4 (Hwang et al., 2001). The experiment was terminated for individual mice 
when the tumour volume exceeded 800 mm³ or when ulceration or bleeding occurred. 
 
2.2.5 Statistical analysis 
Statistical analysis was performed by unpaired t-test with the GraphPad Prism software. Data 
is always depicted as mean ± standard error of the mean (SEM). Statistical significance is 
indicated by asterisks according to the following scheme:  
 






3.1 Investigation of thymocyte development 
The evolutionary highly conserved Hh signalling pathway plays an important role in cell 
differentiation and cell patterning in a wide variety of tissues including the immune system. 
However, its specific role in the development and function of T cells remains controversial, 
although different studies suggested that it might play a role in this cell population as well. To 
address the role of Hh signalling specifically in T cells, the group of Prof. Dr. Heidi Hahn 
developed the CD4Cre+/- Ptchflox/flox mouse which forms the basis of the study at hand. In this 
model, the Cre recombinase is expressed under the control of a CD4 promoter which leads 
to the excision of exons 8 and 9 from Ptchflox alleles. This prevents translation of functional 
Ptch proteins which was expected to cause activation of canonical Hh signalling. The mouse 
model was initially characterised and described by Uhmann and colleagues in 2011. The 
authors showed an almost complete recombination of the Ptch locus in thymocytes which 
was accompanied by a large reduction in the expression of wild type Ptch transcripts in 
favour of an increased expression of non-functional (Ptchdel) transcripts. Despite the 
successful inactivation of Ptch in T cells, no effect on different developmental stages of 
thymocytes could be observed. This, however, was in contrast to several reports in the 
literature which found that active Hh signalling affected the transition of DN to DP and DP to 
SP cells (Rowbotham et al., 2007; Drakopoulou et al. 2010; Furmanski et al., 2012). Since 
the experiments of Uhmann and colleagues had been performed with mice on a mixed 
C57BL/6 and 129/Sv genetic background, I decided to repeat these experiments on a larger 
experimental base and on a pure C57BL/6 background to verify the previously obtained 
results. 
 
Initially, I investigated the morphology and cellularity of thymi from CD4Cre+/- Ptchflox/flox 
mutant and Ptchflox/flox control mice. For this purpose I sacrificed mice from both genotypes 
and dissected the thymus. As shown in Figure 3A, size and morphology were similar for 
thymi from both genotypes. I then prepared single cell suspensions from these organs and 
counted the nucleated cells. With a cell count of around 108, cellularity was within normal 












 mice.  
Twenty week old mice from both genotypes were sacrificed in a carbon dioxide atmosphere 
and the thymi were carefully dissected. (A) One representative thymus from a mouse of each 
genotype is shown. (B) Single cell suspensions were generated from thymi of four mice per 
genotype and live nucleated cells were counted. The diagram shows the mean cell number 
± SEM for both genotypes. 
 
Thymocyte development starts with the immigration of precursor cells from the BM into the 
thymus. A number of distinct maturation stages can be classified based on the expression of 
cell surface markers. The earliest stage is the DN stage in which cells lack surface 
expression of both CD4 and CD8. This stage can be further subdivided into the DN1 (CD25-
CD44+), DN2 (CD25+CD44+), DN3 (CD25+CD44-) and (CD25-CD44-) DN4 stages (Haks et 
al., 1999). Following the expression of a functional  TCR, the cells start expressing both 
CD4 and CD8 in the DP stage before they finally become CD4 or CD8 SP cells. Thus I 
analysed T cell development by staining isolating thymocytes from mice of both genotypes 
with antibodies against CD4, CD8 and CD44 to identify the different developmental stages 
(Figure 4). A direct comparison of early DN cells (DN1 and DN2 stages) before T cell lineage 
commitment and late DN cells (DN3 and DN4 stages) after commitment to the T cell lineage 
is depicted in Figure 4B. As expected from the late activation of the CD4 promoter at the 
DN3 stage, no difference could be seen between the numbers of early DN cells in both 
genotypes. The same was true for late DN cells as well as for the total number of DN cells 
(Figure 4C). Surprisingly and in contrast to previous data obtained from this mouse model, I 
found a small but significant increase in the percentage of DP cells in CD4Cre+/- Ptchflox/flox 
mice compared to mice that lacked expression of the Cre recombinase. This increase in DP 
cells led to a corresponding reduction in the percentage of SP cells which was especially 
pronounced in the CD4 SP population. The observed impact of the Ptch inactivation on the 
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development of T cells encouraged me to investigate whether peripheral T cells were also 
affected by this mutation. 
 
 
Figure 4. Flow cytometric analysis of thymocyte development 






 mice and 
stained for the surface markers CD4, CD8 and CD44 to discriminate between different 
developmental stages. (A) A representative staining of live thymocytes with antibodies 
against CD4 and CD8 is shown for both genotypes. (B) CD4 and CD8 DN thymocytes were 
further subclassified into early DN cells (encompassing DN1 and DN2 stages) and late DN 
cells (encompassing DN3 and DN4 stages) according to the expression of CD44. (C) The 
percentage of total DN cells, CD4 and CD8 DP cells and CD4 or CD8 SP cells are shown. 










3.2 Characterisation of peripheral T cells 
 
3.2.1 Efficiency and molecular effects of Ptch inactivation 
It was previously reported by Uhmann and colleagues that the recombination of the Ptch 
locus along with the expression of the non-functional Ptch allele was already very 
pronounced among thymocytes in mutant mice (Uhmann et al., 2011). Ptch is a negative 
regulator of Smo and represses Smo-mediated activation of the Gli transcription factors in 
the context of the canonical Hh signalling cascade. According to the general understanding 
of this pathway, the inactivation of Ptch should result in derepression of Smo and thus lead to 
the activation of canonical Hh signalling. Contrary to expectations, Uhmann et al. found that 
elevated expression of the Gli transcription factors which are indicative of canonical 
signalling could not be detected in thymocytes. To investigate whether the Ptch deletion led 
to the expected upregulation of Hh target genes in peripheral T cells, I isolated splenocytes 
from mice of both genotypes and performed qRT-PCR to study the expression of relevant 
transcripts (Figure 5). Here I found a strong reduction in the expression of the wt Ptch 
transcript in T cells from CD4Cre+/- Ptchflox/flox mice compared to cells from control mice 
(Figure 5A). In parallel, a corresponding increase in the expression of the non-functional 
Ptchdel transcript could be observed in Cre-transgenic T cells while the transcript was not 
detectable in T cells lacking the Cre recombinase (Figure 5B). Ptch2, a homolog of Ptch 
which shows a highly similar sequence and has been reported to have partially overlapping 
functions with Ptch was also analysed. Expression of Ptch2 however could not be detected in 
Ptch-deficient or control T cells while is was clearly detectable in cDNA generated from a wt 
mouse embryo at E10.5 that served as a positive control. Expression of the Gli transcription 
factors Gli1 and Gli2 which are upregulated upon Hh signalling was similar in Ptch-deficient 
and control T cells. Thus, the obtained data from peripheral T cells were again contrary to the 
expectations but comparable to the results which were previously reported for thymocytes. 
The data suggest that canonical Hh signalling is not active in peripheral T cells either despite 





Figure 5. Gene expression analysis of peripheral T cells 
Splenic T cells were isolated from five Ptch
flox/flox




 mice and 
used to generate cDNA for qRT-PCR analysis. Relative expression of the wild type Ptch 
allele (wt Ptch; A), its truncated form after Cre-mediated excision of exons 8 and 9 (Ptch
del
; 
B), the Ptch homolog Ptch2 (C) as well expression of the transcription factors Gli1 (D) and 
Gli2 (E) are shown. All samples were measured in duplicates and normalized to the 
expression of HPRT1. (nd = not detected) 
 
3.2.2 T cell populations and their activation state in the periphery 
In order to unravel potential effects of Ptch ablation on T cells which do not require the 
activation of canonical Hh signalling, I began to study peripheral T cells. Initially, I focussed 
on the spleen which, as the major secondary lymphoid organ, is an important site of T cell 
homeostasis and activation. For this purpose I dissected spleens from CD4Cre+/- Ptchflox/flox 
mutant and Ptchflox/flox control mice, evaluated their overall appearance and determined the 
total number of nucleated cells. Morphology of spleens from CD4Cre-transgenic mice were 
inconspicuous and did not show any difference to organs which originated from control mice 
(Figure 6A). I then enumerated total cells in the spleens of mice from both genotypes. As 
shown in Figure 6B, the average amounts of nucleated cells in the spleens were 
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approximately 1,3 x 108 for CD4Cre+/- Ptchflox/flox mutant mice as well as for control mice 
showing that the Ptch inactivation does not affect the total number of splenocytes. 
 
 
Figure 6. Comparison of splenic morphology and cellularity  
Spleens were isolated from Ptch
flox/flox




 mutant mice. (A) A 
representative organ from each genotype is depicted. (B) Single cell suspensions were 
generated and live splenocytes counted. The diagram shows the mean cell number ± SEM 
for ten Ptch
flox/flox






Since I was not able to find any differences in the absolute number of cells, I continued to 
investigate the composition of peripheral T cells more closely by flow cytometry. For this 
purpose, I determined the percentage of TCR+ T cells on total lymphocytes and enumerated 
the amount of CD4+ and CD8+ cells among total T cells. This was done for blood, mesenteric 
lymph node as a vital part of the gut-associated lymphoid tissue and the spleen which is 






Figure 7. Flow cytometric analysis of peripheral T cell populations 







 mutant mice. Cells were stained with antibodies against the 
TCR beta chain ( TCR), CD4 and CD8 before they were analysed by flow cytometry to 
identify T cells and their major subpopulations. The percentage of TCR expressing cells is 
given among the lymphocyte fraction together with cells expressing CD4 and CD8 among 
TCR
+





 T cells was calculated and is shown in panel D. All diagrams show the mean 
percentage or ratio ± SEM for at least four Ptch
flox/flox







Percentages of total T cells among leukocytes ranged from 30% in blood to 60% in 
mesenteric lymph nodes but were not significantly different between CD4Cre+/- Ptchflox/flox and 
control mice in all analysed tissues. CD4+ T cells, which were the dominant T cell 
subpopulation, accounted for 55% to 60% of T cells in the blood as well as in mesenteric 
lymph nodes and spleens. This observation could be made for mutant and also for control 
mice. With around 30% to 40% of total T cells, CD8+ cells formed a smaller T cell 
subpopulation and their percentage was also comparable between both analysed genotypes. 
The peripheral CD4 to CD8 T cell ratio is tightly regulated and generally maintained above 1 
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in healthy mice although it decreases with age (Kappes & He, 2005). A number of T cell 
intrinsic factors can lead to a shift of this ratio, including an alteration in the TCR signalling 
strength (Hayes & Love, 2006). Thus, the peripheral CD4 to CD8 ratio can be employed as a 
tool to gain insight into the functionality of T cells. I therefore determined the percentages of 
CD4+ and CD8+ T cells and calculated the ratio between them for blood, mesenteric lymph 
nodes and spleens. I found that it was well above a value of one and ranged from 1,4 in 
mesenteric lymph nodes up to 1,7 in spleens. For every organ analysed, the ratio was highly 
similar between CD4Cre+/- Ptchflox/flox and control mice. Taken together, these data 
demonstrate that the T cell population as a whole and its two major subpopulations were not 
numerically affected by Ptch ablation.  
 
To investigate whether the Ptch-deficiency had more subtle effects on T cells, I focussed on 
both major T cell subpopulations and determined the percentage of cells that were positive 
for CD69 or showed a high expression of CD44 by flow cytometry (Figure 8). CD69 is a 
C-type lectin which is one of the earliest inducible cell surface proteins during lymphocyte 
activation and can thus be used to identify recently activated T cells (Cambiaggi et al., 1992). 
CD44 on the other side is a surface protein that is involved in cell migration and cell-cell 
interactions due to its ability to interact with carbohydrates. Expression of CD44 is 
upregulated following TCR stimulation and is sustained on effector as well as memory cells 






Figure 8. Activation state of peripheral T cells 







 mice. Cells were stained with antibodies against the TCR, CD4, CD8, 
CD69 and CD44 to identify T cell subpopulations and reveal their activation state. Cells 
showing a recently activated (CD69
+
) or effector memory (CD44
hi





 T cell populations for blood (A), mesenteric lymph nodes (B) and 









I found that between 3% and 6% of CD4+ and CD8+ T cells stained positively for CD69 in 
blood and lymph nodes while up to 10% of CD4+ T cells expressed this marker in the spleen. 
A direct comparison of CD4Cre+/- Ptchflox/flox and control mice however did not reveal any 
difference in the amount of recently activated T cells between both genotypes. With around 
15% in lymph nodes and up to 30% in spleens and blood, effector memory T cells as 
identified by their high expression of CD44 represented a much larger fraction of CD4+ and 
CD8+ T cells than recently activated cells. Percentages in this compartment were also highly 
similar between both genotypes, suggesting that Ptch ablation does not considerably impact 





3.3 Functional analysis of conventional T cells in vitro 
Since I could not find any differences in the numbers or activation state of peripheral T cells 
in CD4Cre+/- Ptchflox/flox mice, I switched to in vitro assays in order to study whether Ptch 
ablation had any impact on functional characteristics of T cells. Under physiologic conditions, 
naϊve T cells become activated when they encounter their specific antigen in the periphery. 
Antigen is presented on MHC molecules in the form of a peptide that is between 9 and 25 
amino acids in length. Presentation of antigen is usually performed by professional APCs 
such as dendritic cells and macrophages. The MHC:peptide complex is recognized by the 
TCR and initiates the activation process of the T cells which eventually leads to the secretion 
of cytokines such as the autocrine growth factor IL-2 and the effector cytokine IFN- . This 
process can be mimicked in vitro in the form of a MLR. T cells cultured together with APCs of 
a different MHC haplotype become activated due to the MHC mismatch between both cells. 
This alloreactivity is mainly based on MHC-dominant cross-reactivity of the TCR which 
occurs irrespective of antigen (Whitelegg & Barber 2004). The results of this allogeneic T cell 
stimulation are shown in Figure 9. 
 
 
Figure 9. Allogeneic stimulation of T cells 
10
5






 mice on a C57BL/6 
background and cocultured with an equal amount of BALB/c-derived BMDM in 96-well round-
bottom plates for 72 hours. Thereafter, 50 µl of medium were removed for cytokine analysis 
and replaced with the same amount of fresh medium containing 
3
H-TdR with an activity of 37 
kBq before the cells were incubated for another 16 hours. (A) Incorporation of 
3
H-TdR was 
assessed by scintillation counting and is depicted as counts per minute (cpm). IL-2 (B) and 
IFN-  (C) levels in the supernatant were quantified by ELISA. All samples were measured in 




Proliferation of T cells was assessed after a stimulation period of 72 hours by 3H-TdR 
incorporation for another 16 hours (Figure 9A). With an average of 500 cpm, the proliferation 
was rather weak as expected due to the low percentage of alloreactive cells. T cells isolated 
from CD4Cre+/- Ptchflox/flox mice responded with a proliferation which was comparable to that 
of control mice. In addition, secretion of the growth factor IL-2 and the effector cytokine IFN-  
were measured by ELISA. Consistent with the low incorporation of 3H-TdR, IL-2 levels were 
relatively low with a maximal concentration of less than 60 pg / ml in the supernatant (Figure 
9B). On average, Ptch-deficient T cells produced less of this cytokine but the differences 
remained insignificant. Secretion of IFN-  was much higher for cells of both genotypes and 
ranged from 300 pg / ml up to 500 pg / ml (Figure 9C). Here, T cells that lacked functional 
Ptch produced on average higher amounts of IFN-  but the difference to the amounts 
produced by control cells were not significant either. 
 
Since the allogeneic stimulation affected only few cross-reactive T cells, I wondered whether 
a more general stimulation of all T cells could unravel a potential effect of Ptch ablation on 
the T cell population as a whole. For this purpose, I stimulated T cells polyclonally either with 
the lectin ConA or with stimulating monoclonal antibodies (mAb) directed against the -chain 
of CD3 and against the co-stimulatory molecule CD28. Both stimuli were used at suboptimal 
and optimal concentrations to investigate the T cell response under different conditions. 
Proliferation of T cells was assessed by 3H-TdR incorporation (Figure 10). Under suboptimal 
stimulation conditions, T cells activated with ConA or antibodies against CD3 and CD28 
showed a weak proliferative response that was comparable to the response observed 
following allogeneic stimulation. In contrast, optimal stimulation led to a much stronger 
response of up to 4000 cpm when cells were stimulated with ConA. Under optimal 
conditions, Ptch-deficient T cells showed a slightly stronger proliferation at all time points 
which nonetheless did not reach significance. When suboptimal stimulation was employed, 
proliferation was highly comparable between both genotypes. Data obtained from the 
measurement of IL-2 secretion is shown in Figure 11A. Here, suboptimal stimulation with 
ConA led to an accumulation of the cytokine in the supernatant over time with no significant 
difference being detectable between both genotypes. When anti-CD3 and anti-CD28 
antibodies were used for suboptimal stimulation, an appropriate accumulation of the cytokine 
could not be observed. Application of higher antibody concentrations that led to an optimal 
stimulation in the described system caused an increase in IL-2 secretion with ConA being 




Figure 10. Proliferation of polyclonally stimulated T cells 








 cells per well 
were stimulated in 96-well plates with different concentrations of ConA or mAb against CD3 
and CD28. For suboptimal stimulation, ConA was used at a concentration of 0,5 µg / ml while 
anti-CD3 and anti-CD28 mAb were used at concentrations of 0,01 µg / ml each. Optimal 
stimulation was achieved by adding 2,5 µg / ml ConA or 1 µg / ml anti-CD3 and anti-CD28 
mAb each. After 24, 48 or 72 hours, 37 kBq 
3
H-TdR were added per well prior to another 
incubation period of 16 hours. Incorporation of 
3
H-TdR was measured by scintillation counting 
and is depicted as cpm. The diagram shows the mean ± SEM from two to ten independent 
experiments. Differences are not statistically significant unless otherwise indicated. 
 
In contrast to the data obtained by measuring 3H-TdR incorporation, IL-2 production was by 
trend higher in T cells derived from control mice than in Ptch-deficient cells. This was 
especially true for cells stimulated with ConA, but even here no significant difference 
between both genotypes could be observed. Finally, secretion of the effector cytokine IFN-  
was assessed and the results are shown in Figure 11B. Irrespective of the employed 
stimulus, IFN-  secretion was barely detectable when a suboptimal stimulation was 
performed. In contrast, optimal stimulation of the cells led to a pronounced secretion of the 
cytokine which accumulated in the supernatants over time. Cells from mice of either 
genotype showed a highly comparable IFN-  production in response to stimulation. In 
summary, the data argue against a significant impact of Ptch ablation on both the 






Figure 11. Cytokine secretion of polyclonally stimulated T cells 




 mutant and Ptch
flox/flox
 control mice. 
10
5
 cells per well were stimulated in 96-well plates with different concentrations of ConA or 
antibodies against CD3 and CD28. Suboptimal stimulation was achieved by adding ConA at 
a concentration of 0,5 µg / ml or by adding anti-CD3 and anti-CD28 mAb at concentrations of 
0,01 µg / ml each. For optimal stimulation, ConA was added at a concentration of 2,5 µg / ml 
while anti-CD3 and anti-CD28 mAb were used at 1 µg / ml each. After 24, 48 or 72 hours, 
50 µl of supernatant were collected for cytokine analysis. Quantification of IL-2 (A) and IFN-  
(B) was performed by ELISA and all samples were measured in triplicates. Each diagram 
shows the mean ± SEM from two to ten independent experiments. Differences are not 
statistically significant unless otherwise indicated. 
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3.4 Analysis of naturally occurring regulatory T cells  
Treg cells are a subpopulation of T cells which are capable of negatively modulating immune 
responses. Their primary function was initially defined to be the prevention of autoimmune 
diseases by maintaining self-tolerance but continuous research has revealed several other 
functions. Those include the induction of tolerance against non-harmful environmental 
antigens and a negative feedback control of effector T cell responses. Treg cells come in 
many forms with the naturally occurring Treg cells being the best defined. This subpopulation 
can be identified by expression of several markers including the IL-2 receptor -chain, the 
surface molecule GITR and the transcription factor FoxP3. In mice, FoxP3 is not only a 
marker for Treg cells but also a key regulator in the development and function of this 
population (Zhang & Zhao, 2007). Given the importance that Treg cells play in immune 
responses, I decided to investigate whether Ptch ablation had any effect on this population. 
For this purpose, I enumerated TCR+CD4+CD25+GITR+FoxP3+ Treg cells in the spleens of 
CD4Cre+/- Ptchflox/flox mutant and Ptchflox/flox control mice by flow cytometry (Figure 12A). With 
a percentage of around 9% among CD4+ T cells and approximately 5% among total T cells, 
Treg cells were normally distributed with no significant difference being detectable between 
both genotypes. Expression levels of the transcription factor FoxP3 were quantified by 
determining the mean fluorescent intensity (MFI) of intracellular stainings using FoxP3-
specific antibodies (Figure 12B). FoxP3 expression was evenly distributed among cells and 
was found to be similar between Treg cells that originated from mice of either genotype. A key 
characteristic of Treg cells is their capability to suppress the proliferation and IL-2 secretion of 
activated conventional T cells which can be easily assessed in vitro. For this purpose, I 
isolated Treg cells from mice of both genotypes, cocultured them with conventional CD4
+ 
T cells that were stimulated with anti-CD3 and anti-CD28 antibodies and determined the 






Figure 12. Analysis of naturally occurring Treg cells 






 mice, stained for TCR, CD4, 
CD25, GITR and FoxP3 and analysed by flow cytometry to identify Treg cells. (A) The 
percentage of Treg cells among CD4
+
 T cells is given. (B) Levels of intracellular FoxP3 
expression in Treg cells are shown as MFI. (C) 10
5
 freshly isolated Treg cells were cocultured 
with CD4
+
 Th cells at the indicated ratios. Polyclonal stimulation was achieved by adding anti-
CD3 mAb and anti-CD28 mAb in concentrations of 1 and 5 µg / ml respectively. Unstimulated 
or stimulated Th cells as well as stimulated Treg cells alone served as controls. After 48 hours, 
the supernatants were removed and used to determine IL-2 levels which were normalised to 
samples derived from activated Th cells. Diagrams show the mean ± SEM from three 
(Ptch
flox/flox




) independent experiments. 
 
While CD4+ Th cells responded to the stimulation with a high secretion of IL-2, Treg cells did 
not secrete detectable amounts of this cytokine as expected. A coculture of Treg cells and 
Th cells at different ratios revealed a ratio-dependent suppression of cytokine production by 
Treg cells. Both the response of Treg cells to activation and their suppressive capacity were 
however not influenced by ablation of functional Ptch. The obtained data therefore are not in 





3.5 Susceptibility of T cells to apoptosis  
Programmed cell death or apoptosis is a key process for proper tissue development and 
homeostasis in metazoans. It is also vital for the correct function of the immune system due 
to its implication in virtually every stage of lymphocyte development and activity. Shaping of 
the T cell repertoire in the thymus is highly dependent on apoptosis during the processes of 
positive and negative selection while it is also crucial for the termination of immune 
responses upon pathogen clearance and in the prevention of autoimmunity. Due to the 
central importance of programmed cell death in T cell development and activity, I decided to 
investigate whether it is affected by the Ptch deficiency. Therefore, I isolated T cells from 
CD4Cre+/- Ptchflox/flox and control mice and investigated their susceptibility to apoptosis in 
response to three different stimuli. I treated cells either with the synthetic glucocorticoid 
dexamethasone (Dex), exposed them to -radiation or incubated them in medium that was 
devoid of survival factors such as IL-2. The percentage of live cells was determined daily by 
flow cytometry using 7-AAD as a marker for apoptotic cells that had lost their membrane 
integrity. The results of this experiment are depicted in Figure 13. 
 
 
Figure 13.  Sensitivity of resting T cells to apoptosis  
2 x 10
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 mice were treated 
with Dex, exposed to -radiation or left unmanipulated. Viability was assessed daily by FACS 
analysis using 7-AAD as a marker for apoptotic cells. (A) Cells were treated with 2 or 6 nM 
water-soluble Dex to induce apoptosis or left untouched. The diagram shows the combined 
data from three independent experiments per genotype. (B) Cells were exposed to -radiation 
at doses of 0,5 or 1,5 Gy or not irradiated at all. The combined data from three independent 





In the absence of exogenous survival factors, T cell viability rapidly declined and reached a 
value of less than 60% after 24 hours which further decreased to less than 30% after 48 
hours (Figure 13A, upper curve). 96 hours after the start of the experiment, only very few live 
cells could still be detected in the culture. Addition of 2 nM Dex into the medium accelerated 
this process and T cell viability reached a value of less than 30% after 24 hours and dropped 
down to less than 3% within the following 24 hours (Figure 13A, middle curve). When Dex 
war added at a higher concentration of 6 nM, cell viability reached a value of approximately 
10% already after 24 hours and no viable cells were detectable 48 hours after the start of the 
experiment (Figure 13A, lower curve). Under all conditions, Ptch-deficient T cells showed a 
highly similar response compared to control T cells. In parallel, cells were subjected to 
different doses of -radiation (Figure 13B). An exposure of T cells to a dose of 0,5 Gy led to a 
considerable drop in viability after 24 hours whereas a dose of 1,5 Gy had a even more 
severe effect on cell survival and led to a reduction of cell viability to approximately 5% after 
24 hours of culture. A difference between Ptch-deficient and control T cells could not be 
observed in this setting either, suggesting that Ptch ablation did not affect the susceptibility of 
resting T cells to apoptosis.  
 
Upon activation, T cells are known to acquire an increased resistance to apoptosis due to the 
upregulated expression of several Bcl-2 family proteins which regulate the apoptotic 
pathways. During an ongoing immune response, this is highly beneficial for the organism 
since it accelerates removal of the pathogen. Because I was not able to observe an effect of 
Ptch on the susceptibility of resting T cells to apoptosis, I wondered whether Ptch ablation 
might specifically affect this regulatory network in activated T cells. In order to explore if this 
was the case, I isolated T cell from mice of both genotypes and prestimulated them either 
with anti-CD3 and anti-CD28 mAb or with ConA for 24 hours (Figure 14). Subsequently, I 
added the synthetic glucocorticoid Dex to amplify apoptosis induction. Due to the higher 
tolerance threshold of activated T cells against glucocorticoids, I increased the concentration 





Figure 14. Sensitivity of activated T cells to apoptosis  
2 x 10
5






 mice and 
prestimulated either with 2,5 µg / ml ConA (A) or with 1,5 µg / ml anti-CD3 mAb and anti-
CD28 mAb (B) for 24 hours. Afterwards, 1 µM water-soluble Dex was added to induce 
apoptosis or cells were left untreated. Viability was assessed daily by FACS analysis using 
7-AAD. Diagrams show the mean ± SEM from four Ptch
flox/flox





 mutant mice. 
 
I observed that in the absence of Dex, T cell viability initially declined but stabilized at 
approximately 15% from day four after the start of the experiment (Figure 14A). This differed 
from the response of resting T cells and underlined the reduced susceptibility of activated T 
cells towards apoptosis. There was however no difference in the response of Ptch-deficient 
versus control T cells. Addition of Dex further reduced the viability of T cells which reached 
its minimum level of approximately 5% on day four after apoptosis induction. Again cells from 
CD4Cre+/- Ptchflox/flox and control mice behaved in a similar fashion. When T cells were 
preactivated with stimulating mAb against CD3 and CD28 instead of ConA, survival during 
the preactivation phase was much better (Figure 14B). Nevertheless, viability of T cells 
declined to a value of less than 20% on day four. Addition of Dex again had a pronounced 
negative effect on T cell survival with less than 10% of T cells being alive after four days. A 
different behaviour between Ptch-deficient and control T cells, could not be observed either. 
In summary, the obtained data argues against a role of Ptch in the susceptibility of both 





3.6 In vivo analysis of Ptch-deficient T cells 
 
3.6.1 Allergic airway inflammation 
Since I had not observed any significant difference in the distribution of T cells in vivo or their 
function in vitro, I wondered whether a potential impact of Ptch ablation might become 
evident only under physiological conditions during immune responses in vivo. For this 
purpose I initially studied T cells in allergic airway inflammation experiments which represent 
an experimental model of human asthma, a chronic inflammatory disorder of the airways that 
is characterised by reversible airflow obstruction, airway inflammation and airway 
remodelling. A murine model for allergic airway inflammation can not only provide insights 
into the mechanisms underlying the development of human asthma, but can also be used as 
a valuable tool to investigate the function of different T cell populations during an immune 
response in vivo. Thus I decided to investigate whether the Ptch deficiency in T cells affects 
a Th2 biased immune response in this model. To this end, I sensitised CD4Cre
+/- Ptchflox/flox 
and Ptchflox/flox mice against Ova in the presence of the Th2-promoting adjuvant Alum and 
evaluated the elicited immune response according to different parameters after intranasal 
antigen challenge.  
Initially I focussed on the lungs where I enumerated infiltrating inflammatory cells and 
characterised them by flow cytometry (Figure 15). In control mice which were challenged with 
but not previously sensitized against Ova, I found on average less than 4 x 104 cells in the 
BALF (Figure 15A). In contrast, mice that were previously sensitized against the antigen 
showed a more than 8-fold increase in total cell numbers. Differences between CD4Cre+/- 
Ptchflox/flox and Ptchflox/flox mice were marginally, however, and did not reach statistical 
significance. In-depth characterisation of airway-infiltrating cells is shown in Figure 15B/C. 
Upon antigen challenge, cellular inflammation was largely dominated by eosinophils which 
on average accounted for 70% of total cells. A clear increase could also be seen in the 
numbers of CD4+ T cells whereas neutrophil granulocyte numbers were only slightly elevated 
in sensitised mice. In contrast, fewer macrophages could be detected as compared to control 
mice. Among all analysed cell populations, numerical differences between sensitised mice of 
both genotypes remained insignificant. Thus, both the absolute number of lung-infiltrating 
cells as well as their cellular composition showed no indication for an impact of Ptch 





Figure 15. Lung infiltration in allergic airway inflammation experiments 







 mice with 10 µg Ova together with 1,5 mg Alum. Control 
mice (Ptch
flox/flox
) were treated with Alum alone. All mice were challenged ten days after final 
sensitisation by intranasal application of 150 µg Ova dissolved in PBS on three consecutive 
days. Analysis was performed after a one day resting phase. (A) Mice were sacrificed and the 
lungs were rinsed with PBS to obtain the BALF in which total nucleated cells were counted by 
light microscopy. (B) FACS analysis was performed with BALF cells to identify different 
populations according to the expression of CD3, CD4, CD11b, F4/80, Siglec-F and Ly-6G/C. 
A representative FSC versus SSC plot is shown for each group. T cells appear in blue, 
neutrophil granulocytes in orange, macrophages in green and eosinophil granulocytes in red. 
Cell debris was identified by low FSC values and has been excluded. (C) Mean numbers of 
different infiltrating cell population from the FACS analysis of BALF cells are depicted. 
Diagrams show the mean ± SEM for nine control mice, thirteen Ptch
flox/flox












I next performed histopathological studies of lungs to investigate structural changes present 
in the airways and lung parenchyma upon antigen challenge (Figure 16). In control mice, the 
lung tissue appeared normal with few nucleated cells being distributed among alveoli (small 
hollow structures) and around bronchioles (larger hollow structures; Figure 16A). In Ptchflox/flox 
mice that were sensitised and challenged with Ova, I could observe severe differences 
compared to control mice (Figure 16B). Tissue-infiltrating nucleated cells were massively 
increased in numbers and accumulated around the airways. In addition, thickening of the 
airway walls could be observed along with increased mucus secretion that narrowed the 
lumen of bronchioles. Tissue samples from CD4Cre+/- Ptchflox/flox mice also showed a massive 
cellular infiltration that closely resembled the situation seen in Ptchflox/flox mice with no obvious 
difference being recognizable (Figure 16C).  
 
Figure 16. Histologic analysis of lung tissues in allergic airway inflammation 
experiments 
Mice from allergic airway inflammation experiments were sacrificed 48 hours after the final 
antigen challenge. Lungs were dissected, fixed in 4% paraformaldehyde and embedded in 
paraffin from which 5 µm slices were prepared. A HE stain was performed on the slices 
before they were analysed microscopically. Representative images are shown from control 







 (C) mice. Scale bars in the lower right corner of all images equal 
100 µm.  
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In order to investigate whether the elicited immune response was Th2-biased as intended 
and to evaluate its strength, I determined the amount of Ova-specific immunoglobulins in the 
serum of mice (Figure 17A). While Ova-specific antibodies were virtually absent in control 
mice, those that had been immunised and challenged with antigen showed high titers of 
specific antibodies in the serum. These were predominantly of the IgG1 isotype which is 
indicative of a pronounced Th2 response. Antibodies of IgG2a and IgE isotypes were also 
increased to a certain extent in immunised mice. However, serum titers of all three isotypes 
were comparable between CD4Cre transgenic and non-transgenic mice. Finally, I isolated 
splenocytes from mice of all groups and restimulated them ex vivo with Ova (Figure 17B). 
While the proliferative response was increased as compared to cells isolated from control 
mice, it was also similar between cells obtained from CD4Cre+/- Ptchflox/flox and Ptchflox/flox 
mice. In summary, despite the different readouts that were used to evaluate the immune 
response in this model of allergic airway inflammation, no impact of the Ptch-deficiency on 
T cell function could be observed. 
 
 
Figure 17. Antibody response and T cell function after induction of allergic airway 
inflammation. 
(A) Serum was prepared from blood 48 hours after the last antigen challenge. Ova-specific 
immunoglobulins of IgG1, IgG2a and IgE isotypes were quantified by ELISA and are shown 
in the form of optical densities (OD). Results represent data from nine control mice and fifteen 
mice from both experimental groups. (B) Splenocytes were isolated and restimulated ex vivo 
with 10 µg / ml Ova for 72 hours. Proliferation was quantified using 
3
H-TdR incorporation and 
is given as cpm. Measurements were performed in triplicates. The diagram shows combined 





3.6.2 Acute Graft-versus-Host disease 
GvHD is a common complication following the transplantation of immunocompetent 
allogeneic tissue. Its main cause are mature CD4+ and CD8+  T cells which become 
activated by a broad range of host antigens and subsequently engage host tissues. This 
occurs through the production of large amounts of inflammatory cytokines and through cell-
mediated cytotoxicity. Due to its dependency on the function of both Th cells and CTLs and 
its well understood pathophysiology, murine models for the acute form of GvHD can also be 
used to investigate the functionality of these T cell subpopulations in a physiologic setting. 
Therefore I decided to employ a model of allogeneic aGvHD to investigate a potential effect 
of Ptch ablation on T cells in vivo. For this purpose I sublethally irradiated BALB/c mice and 
reconstituted them with allogeneic BM that contained a defined number of mature allogeneic 
T cells. Control mice received T cell depleted BM only after irradiation. Progression of the 
disease was regularly evaluated based on several clinical symptoms which were combined 
into a mean clinical score (Figure 18A).  
 
 
Figure 18. Disease course of aGvHD 
Induction of aGvHD was initiated by total body irradiation of male BALB/c mice with a dose of 
8,5 Gy. On the following day, mice received 10
7
 T cell depleted allogeneic BM cells with 
(experimental groups) or without (control groups) 2 x 10
6







 mice. (A) Animals were monitored regularly for different clinical 
symptoms that were combined into a mean clinical score with a maximum of 10. (B) Survival 
was monitored regularly for experimental and control groups. Both figures show combined 
data from six independent experiments with twenty-nine mice per experimental group and 
thirteen mice for the control group. Clinical score is given as the mean ± SEM. 
 
Starting from approximately day 5 after cell transfer, mice began to show a declining health 
status which was mainly characterized by weight loss, absent grooming and reduced activity. 
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The mean clinical score reached a preliminary peak 6 to 8 days after the cells had been 
transferred and began to decline again. Control mice which had not received T cells did also 
show clinical symptoms which peaked at the same time point but were less pronounced. 
Mice from all groups partially recovered in the following days and showed only mild but 
persistent symptoms for a time period of roughly 10 days. Approximately three weeks after 
cell transfer, the health status of mice began to decline again and clinical symptoms, which 
now frequently included diarrhoea, quickly exceeded the values of the initial peak and 
eventually led to the death of individual mice. In contrast, control mice which had only 
received T cell depleted BM became virtually free of symptoms 5 weeks after the experiment 
had been started. Notably, disease progression as assessed by observable symptoms was 
almost congruent between groups that received Ptch-deficient or control T cells. In parallel, 
survival of animals was also assessed and is depicted in Figure 18B. When T cells were 
administered, 10% of mice died on average during the initial disease phase which occurred 
before day 10 after cell transfer. Only few mice deceased during the recovery phase until the 
survival rate began to constantly drop starting after day 20. Although survival during the initial 
phase was slightly better in groups which received wt T cells, the overall survival curves were 
again highly similar between groups that received Ptch-deficient or control T cells and 
revealed no significant difference in disease progression.  
 
In addition to evaluating the severity of aGvHD using clinical parameters that were assessed 
visually, I also determined body temperature and blood glucose levels during the first 10 
days of the experiments (Figure 19). These factors are not directly related to an aGvHD 
reaction but can be used to indirectly evaluate the health status of the mice. Body 
temperature of animals that had received BM in combination with T cells constantly declined 
starting from day 4 after cell transfer while temperature from control mice remained relatively 
constant (Figure 19A). At all time points, values for mice that had received Ptch-deficient or 
control T cells were highly comparable. Assessment of blood glucose levels also gave similar 
results and showed that levels declined by trend in groups that received T cells while control 
animals were less affected (Figure 19B). As before, no significant difference between both 
experimental groups could be observed. Thus the obtained results from aGvHD experiments 




Figure 19. Body temperature and blood glucose levels in aGvHD 
Acute GvHD was induced as described before. From day two until day ten after cell transfer, 
body temperature was determined rectally using a rodent thermometer (A) and glucose levels 
were measured in blood that was collected from the tail vein (B) every other day. Figures 
show the mean value ± SEM from thirteen mice of the experimental groups and from four 
control mice.  
 
3.6.3 B16 Melanoma model 
Although I had previously investigated the peripheral distribution of naturally occurring Treg 
cells and CTLs in vivo and the functionality of Treg cells in vitro, I wondered whether ablation 
of Ptch might exert a subliminal effect on these cell types that could only become evident in 
vivo. Both cell types are known to play critical roles during anti-tumour immune responses 
which persuaded me to employ an in vivo tumour model in order to analyse the functionality 
of these cells in a physiologic setting. Tumour-specific CTLs are highly effective in the 
elimination of neoplastic cells while Treg cells, which are also recruited in large numbers into 
the tumour microenvironment, can suppress the function of anti-tumour effector cells and 
thereby promote tumour growth. In order to investigate the function of both cell types in vivo 
in the context of an anti-tumour immune response, I inoculated CD4Cre+/- Ptchflox/flox and 
control mice subcutaneously with 104 B16F10 melanoma cells and evaluated the 
development of primary tumours (Figure 20). Subcutaneous tumours initially became visible 
on control mice ten days after the cells had been transferred and affected all mice by day 22 
of the experiment (Figure 20A). Tumour onset and progression were comparable between 
control and CD4Cre+/- Ptchflox/flox mice. Individual tumour growth was also measured and is 
shown in Figure 20B. Starting approximately from day 14 after cell inoculation, the tumours 
entered an exponential growth phase and quickly reached volumes of more than 300 mm³ 
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after another seven days. Individual tumour development however was again highly similar 
between both genotypes. 
 
 








 mice were inoculated with 10
4
 B16F10 melanoma cells 
into the right flank. Mice were monitored frequently for palpable tumour and their incidence 
(A) and size (B) were recorded over a period of three weeks. Both graphs show the mean 
± SEM from the combined data of eleven Ptch
flox/flox






Although as little as 104 B16F10 cells were inoculated, primary tumours grew fast and 
became visually detectable already on day ten after cell transfer. Being part of the adaptive 
immune system, T cells which were in the focus of this experiment require a certain amount 
of time to recognize their specific antigen, expand and differentiate from naϊve T cells to 
armed effector cells. Thus it was highly conceivable that a potential impact of Ptch ablation 
on T cell function did not become visible due to the high growth rate of the melanoma cells. 
Furthermore, B16F10 cells are known to be poorly immunogenic which might have further 
exacerbated the induction of an adaptive immune response (Wang et al., 1998). To 
overcome this problem, I vaccinated the mice with a mixture of inactivated B16F10 cells and 
adjuvant in order to elicit a protective anti-tumour immune response. Subsequently, I 
challenged the mice with 104 live B16F10 cells and observed the development of primary 




Figure 21. Development of subcutaneous tumours after inoculation of B16F10 
melanoma cells in immunised mice 







 mice by immunising them with 10
6
 lethally irradiated cells mixed with 
CFA into the left flank. After ten days, mice were challenged with 10
4
 live B16F10 cells into 
the right flank and incidence (A) and size (B) of developing tumours were recorded over time. 







 mice each. 
 
The anti-tumour vaccination delayed tumour onset which did not occur prior to day 13 after 
cell inoculation (Figure 21A). Interestingly, the tumour incidence rate could also be reduced 
to approximately 70% whereas the growth rate of individual tumours that managed to 
outgrow the immune response was not affected (Figure 21B). Despite the protective effect of 
the anti-tumour vaccination which clearly demonstrated partially successful engagement of 
the adaptive immune system, no difference in tumour onset, incidence rate or growth could 
be observed between CD4Cre+/- Ptchflox/flox and control mice. Thus, my data suggests that the 
Ptch-deficiency does not impact on the function of Treg cells or CTLs during an immune 






The Hh signalling pathway specifies cell fate and patterning during embryonic development 
and is involved in homeostasis and renewal of several adult tissues including skin, lung, 
intestine and thymus. Furthermore, there is evidence that genes which are involved in cell 
fate decisions during development may also play a role in the continuous decisions made by 
cells of the adaptive immune system during responses against pathogens (Benson et al., 
2004). The role of Hh signalling in the development and function of T cells however remains 
unclear due to the few groups that have investigated this topic, their different experimental 
approaches and their largely contradictory results. To gain further insights into the role of this 
signalling pathway in T cells which are central constituent of the adaptive immune system, 
the group of Prof. Dr. Heidi Hahn has developed a mouse model in which the Hh receptor 
Ptch is specifically inactivated in T cells. This CD4Cre+/- Ptchflox/flox mouse formed the basis of 
this study. In this model, inactivation of Ptch occurs at the DN3 stage of thymocyte 
development due to the activity of a CD4 promoter-controlled Cre recombinase which 
catalyses excision of two exons from Ptchflox alleles. According to the general view of Hh 
signalling, it was expected that the lack of functional Ptch would lead to the activation of 
canonical Hh signalling that in turn might effect development and/or function of T cells. In this 
context, different in vitro and in vivo approaches were performed to unravel potential effects 
of the Ptch ablation on this cell population.  
 
4.1 Thymocyte development is marginally affected by the Ptch ablation while 
numbers, distribution and activation states of peripheral T cells remain 
unaltered 
In previous analysis that were performed with CD4Cre+/- Ptchflox/flox mice on a mixed C57BL/6 
and 129/Sv genetic background, it was found that thymocyte development was normal and 
indistinguishable from Ptchflox/flox control mice (Uhmann et al., 2011). Since this was in 
contrast to several other reports which found that Hh signalling affected the development of 
thymocytes (Rowbotham et al., 2007; Drakopoulou et al. 2010; Furmanski et al., 2012), I 
initially focussed my analysis on T cell development in CD4Cre+/- Ptchflox/flox mice which had 
been backcrossed to the C57BL/6 genetic background. My first observations were that 
neither the size of the thymi nor the total numbers of thymocytes were altered as compared 
to control mice, thus indicating that T cell development was not grossly affected by Ptch 
ablation. Flow cytometric analysis of different developmental stages revealed that neither the 
percentage of early DN cells which were not yet committed to the T cell lineage, nor of late 
DN cells after T lineage commitment were altered between both genotypes. This observation 
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was expected and can be explained by the “late” activation of the CD4 promoter which does 
not occur before the DN3 stage of thymocyte development (Wolfer et al., 2001). Considering 
the time that is needed for the expression of the Cre recombinase following promoter 
activation, the Cre mediated recombination of the Ptchflox alleles and the decrease of 
functional Ptch due to normal protein turnover, one would assume that a potential effect of 
the Ptch inactivation might not become evident before the DP stage. Indeed, when I 
investigated thymocyte development beyond the DN stage, I found that the percentage of DP 
cells was increased in CD4Cre transgenic mice with a corresponding reduction in the 
CD4 SP and CD8 SP cell compartments. These differences were qualitatively in line with 
some previous reports that studied the effect of Hh signalling on developing thymocytes. 
Despite being statistically significant however, the differences were only of a small magnitude 
and barely affected the overall composition of thymocytes. For this reason, the results need 
to be treated with caution since they might indicate an effect of the Ptch inactivation on T cell 
development but could also be the result of a side effect following the expression of the Cre 
recombinase. Although no such observations have been specifically reported in CD4Cre 
transgenic mice, it is known that expression of the Cre recombinase itself can already induce 
a stress response leading to decreased cell growth, chromosomal aberrations and several 
metabolic alterations in different cell types (Silver and Livingston, 2001; Xiao et al., 2012).  
 
In order to investigate whether the observed differences in thymocyte development had any 
implications for peripheral T cells, I continued by studying the frequency, composition and 
activation state of this population. I started by evaluating the spleen as the largest secondary 
lymphoid organ but was unable to find differences in either the size of the organ or the total 
amount of harboured cells indicating that T cell homeostasis was not generally disturbed. 
Further analysis of both the percentage of T cells among immune cells in different peripheral 
sites as well as the percentage of both major T cell subsets among total T cells also failed to 
reveal any difference between CD4Cre+/- Ptchflox/flox and control mice. Accordingly, the ratio of 
CD4+ to CD8+ T cells which can be indicative of altered TCR signalling was unchanged as 
well. Together these data demonstrated that the observed marginal difference in the 
development of thymocytes neither led to an impaired homeostatic regulation of T cell 
numbers in the periphery nor to an imbalance within the T cell compartment. Since the 
maintenance of the homeostatic equilibrium involves cellular interactions, the competition for 
survival factors such as IL-7 along with the regulation of proliferation and cell death (Marrack 
et al., 2000; Tan et al., 2002), these data suggested that not only T cell numbers were 





Since until then I had only investigated T cells without an immunological context, I continued 
to focus on T cells that had already been in contact with their specific antigen in vivo. Using 
flow cytometry, I identified recently activated T cells and effector memory T cells in different 
immunologically relevant sites. I found that up to 30% of CD4+ and CD8+ T cells were highly 
positive for CD44 and thus had already became activated in response to foreign antigen. In 
addition, 5-10% of both populations had encountered antigen recently as indicated by CD69 
expression. Hence, despite the fact that the mice were kept under SPF conditions, they were 
regularly exposed to pathogens that challenged the adaptive immune system. Notably, I was 
not able to see differences in the percentage of T cells that showed either a recently 
activated or effector memory phenotype between both genotypes. This was a first loose 
indication that T cell responses can be elicited in vivo and lead to the differentiation of naϊve 
T cells into effector cells irrespective of the presence of functional Ptch. 
 
4.2 Ptch does not impact on functional characteristics of T cells in vitro 
During the flow cytometric phenotype analysis of T cells, I had already found some 
indications that the Ptch inactivation was not only largely dispensable for the development 
and homeostasis of T cells, but might also be expendable for at least some of their functional 
characteristics. Yet it might have been possible that functional impairment existed which did 
not affect the cells in a way that became apparent in these analysis. For this reason I 
performed several in vitro experiments which specifically aimed at the investigation of 
functional characteristics of T cells. Initially I performed a MLR which is based on the 
alloreactivity of T cells against MHC-mismatched APCs and represents a useful experimental 
tool to investigate T cell responses in vitro. According to the expectations, T cell proliferation 
was rather weak in this setup. This is a common feature of MLRs and is caused by the low 
frequency of alloreactive T cells which become activated (Sherman and Chattopadhyay 
1993). The proliferative response however was highly comparable between Ptch-deficient 
and control T cells. Secretion of the autocrine survival factor IL-2 and the effector cytokine 
IFN-  were also not significantly different between both groups. Although Ptch-deficient 
T cells showed on average a tendency towards slightly lower IL-2 and higher IFN-  
production, the differences were not only contrary but also highly inconsistent between 
individual experiments thus arguing against a biologic relevance. By employing this 
experimental approach, I was therefore not able to observe any meaningful difference 
between Ptch-deficient and control T cells. 
 
Since the number or responding T cells following an allogeneic stimulation ranges from only 
1-10% (Kovalik et al., 2000), I considered it possible that this circumstance might have 
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masked a potential effect of Ptch on T cell activation in MLR experiments. In addition, the 
limited availability of costimulation in this setup might have also contributed to these 
observations by favouring the activation of T cells that received very strong signals through 
the TCR while those with an average affinity for the MHC:peptide complex might have been 
unable to overcome the activation threshold. I therefore continued with the analysis of T cell 
responses following polyclonal activation which theoretically affected all T cells equally. In 
addition to employing ConA which is a commonly used polyclonal mitogen, I also stimulated 
cells with activating antibodies against the TCR-associated signalling molecule CD3 and the 
costimulatory molecule CD28. In this way, I could employ a less artificial form of stimulation 
compared to ConA-mediated activation on the one hand and ensure that the T cells would 
receive both primary and costimulatory signals on the other hand. All stimulations were 
additionally conducted at suboptimal and optimal concentrations to allow the detection of 
beneficial and attenuating effects, respectively. As a readout, both the proliferation rate and 
the secretion of the cytokines IL-2 and IFN-  were assessed at different time points. Despite 
this extensive setup, I was unable to observe any significant difference between Ptch-
deficient and control T cells. Under optimal stimulation conditions, the proliferative response 
was by trend only slightly stronger in cells that lacked expression of functional Ptch while it 
was similar under suboptimal conditions as observed during MLR experiments. This slight 
and insignificant increase in proliferation however did not correlate with the secretion of IL-2 
which was even slightly lowered in Ptch-deficient T cells when ConA was used as a stimulus 
or equal when the cells were stimulated with antibodies. Secretion of IFN-  was highly 
comparable under all conditions and at all time points. Taken together, the data again argued 
against a role of Ptch in T cells during the activation and expansion phases. Neither the 
capability of T cells to transduce signals via the TCR:CD3 complex nor the reception of 
costimulatory signals through CD28 seemed to be reinforced or disturbed. Following the two-
signal activation, the cells were fully capable of secreting as well as responding to IL-2 and 
subsequently undergo mitosis during the clonal expansion phase. Production of the effector 
cytokine IFN-  which requires proper priming of naïve T cells also appeared to be unaffected. 
Thus, several key characteristics of conventional T cells were not altered following Ptch 
ablation. 
 
Although I found no evidence that the function of conventional T cell was affected by ablation 
of Ptch in my model, I wondered whether the same was also true for Treg cells. This 
specialised T cell subpopulation fulfils specific tasks in the immune system by maintaining 
tolerance to self-antigens and dampening both physiological and pathological immune 
responses. Similar to conventional T cells, naturally occurring Treg cells arise from DP 
precursors in the thymus, albeit at lower numbers. The observed increase in the percentage 
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of DP cells in thymi from CD4Cre+/- Ptchflox/flox mice thus may have indicated a potential effect 
on this population. I found however, that the number of peripheral Treg cells was highly 
comparable between mice that lacked expression of functional Ptch and control mice. This 
excluded that the development of naturally occurring Treg cells in the thymus was numerically 
affected as well as their maintenance in the periphery. Next I determined the expression level 
of the transcription factor FoxP3 in Treg cells but found it not to be altered either. Since FoxP3 
is not only required for proper function of Treg cells but its expression also correlates with the 
functional status of Treg cells (Chauhan et al., 2009), these data already indicated that not 
only the frequency of Treg cells might be unaltered but also their suppressive capacity. Indeed 
when I performed a suppression assay where I cocultured Treg cells with activated 
conventional T cells, I could not observe any differences between cells that were deficient for 
Ptch versus control cells. Treg cells from mice of both genotypes did not respond to 
stimulation and were equally potent in the ratio-dependent suppression of conventional T cell 
proliferation. Hence the obtained data argue against a role of Ptch in the development and 
function of naturally occurring Treg cells. Due to the focus of my studies on this specific 
subpopulation, however, I cannot exclude effects of Ptch ablation on induced Treg cells which 
develop in the periphery and also play important roles during inflammatory responses. 
 
Apoptosis is a process of controlled cell death that occurs as part of normal tissue 
development but is also implicated at virtually every stage of lymphocyte development and 
function. Not only does it mediate the removal of non-functional or potentially autoreactive 
cells in the thymus but it is also crucial for shutting down immune response after pathogen 
clearance and for the deletion of autoreactive cells that escaped into the periphery. 
Considering its relevance, I decided to explore whether Ptch might influence this process in 
T cells. Initially, I studied apoptosis of resting cells which was induced by survival factor 
deprivation in cell culture, by Dex treatment or by -radiation. All three stimuli lead to the 
induction of apoptosis by activating the intrinsic or mitochondria-mediated apoptotic pathway 
which is characterised by the permeabilisation of the mitochondrial membrane and 
subsequent release of cytochrome c into the cytoplasm. This leads to the formation of a 
multi-protein complex which initiates activation of the caspase cascade through caspase 9 
eventually leading to the degradation of cellular constituents. In my experiments, I found that 
apoptosis occurred similarly in Ptch-deficient and control T cells irrespective of the stimulus 
indicating that the Ptch ablation did not affect the intrinsic apoptotic pathway in resting 
T cells. However, one critical feature of activated T cells is their reduced susceptibility to 
apoptosis which improves their effectiveness during an immune response. This is due to the 
increased expression of several Bcl-2 family members such as the anti-apoptotic proteins 
Bcl-2 and Bcl-XL. In addition, activated T cells also upregulate the expression of numerous 
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pro-apoptotic proteins including members of the Bcl-2 homology 3 (BH3)-only subgroup BIM 
and PUMA (Broome et al., 1995; Erlacher et al., 2006). Together, these proteins tightly 
regulate the mitochondrial apoptotic pathway through activation or inhibition of the Bcl-2 
family members Bax and Bak (Sentman et al., 1991; Strasser et al., 1991; Puthalakath and 
Strasser, 2002). Speculating about a possible involvement of Ptch in the anti-apoptotic 
regulation process in activated T cells, I continued to investigate apoptosis susceptibility in 
activated T cells. Indeed I found that resistance to apoptosis in general was strongly 
increased upon cell activation but an influence of Ptch could not be revealed in this context 
either. Taken together, no evidence could be found that Ptch is involved in the process of 
programmed cell death in both resting and activated T cells. It is noteworthy however that all 
employed stimuli focussed on the activation of the intrinsic apoptotic pathway. The extrinsic 
pathway on the other hand is activated upon ligand binding to death receptors of the TNFR 
family including TNFR-1 and Fas which are expressed on the cell surface. Although both 
pathways converge in the caspase cascade which eventually leads to apoptosis, it cannot be 
excluded from the obtained data that Ptch might interfere with the extrinsic pathway before 
caspase activation and thus modulate apoptosis. 
 
4.3 Expression of Ptch in T cells is dispensable for adaptive immunity 
Although I found that Ptch ablation only slightly affected thymocyte development and did not 
impact on the peripheral distribution of T cells or their functionality in vitro either, I still 
considered it possible that it might exert a subliminal effect which might only become evident 
in functional in vivo studies. For this reason I employed three different disease models which 
focussed on the function of different T cell subpopulations. 
 
In my first approach I performed allergic airway inflammation experiments as a model for 
human asthma. In this model, mice were sensitised against Ova to elicit a Th2-biased 
immune response which was evaluated upon intranasal challenge with the antigen. This led 
to an extensive influx of inflammatory cells into the airways which was dominated by 
eosinophils but also comprised CD4+ T cells, macrophages and neutrophil granulocytes. By 
using histological analysis, a strong cellular infiltration could also be observed in the lung 
tissue where cells accumulated around bronchioles. Furthermore, the induction of a humoral 
immune response could be detected where IgG1 was the predominant isotype which 
identified the response to be Th2-biased. While all observed features were characteristic for a 
murine model of allergic airway inflammation (Ohkawara et al., 1997), no difference could be 
found between sensitised mice regardless of functional Ptch expression in T cells. Thus, the 
antigen-driven differentiation of naïve Th0 cells into Th2 effector cells which plays a central 
DISCUSSION 
 89 
role in this model appeared not to be affected. Indirect evidence further suggested that 
production of the Th2-specific cytokines IL4, IL-5 and IL-13 was also not altered. Influx of 
inflammatory cells into the lungs depends on IL-4 and IL-13 which induce expression of 
vascular cell adhesion molecule-1 (VCAM-1) on the vascular endothelium thus directing 
cellular infiltration (Moser et al., 1992; Bochner et al., 1995). In addition, IL-4 synergizes with 
IL-5 in promoting eosinophil survival, activation and chemotaxis through the increased 
expression of eotaxins (Mochizuki et al., 1998; Collins et al., 1995) and in directing B cell 
class switching to IgG1-secreting cells. Although these cytokines are not exclusively 
produced by T cells, the obtained results strongly suggested that the capability of Th2 cells to 
secrete specific cytokines was not affected in this model either.  
 
Next I studied a potential effect of Ptch on T cell function during a Th1-biased immune 
response in a murine model for aGvHD. This model is based on the alloreactivity of CD4+ 
and CD8+ donor T cells which are transferred into an immunodeficient and H-2 incompatible 
recipient. Upon activation by donor and host APCs, T cells expand and cause severe 
cytotoxicity in various tissues which leads to a systemic syndrome of weight loss, diarrhoea, 
skin changes and high mortality. Indeed I could observe that the health status of mice began 
to decline quickly and reached a preliminary minimum around day seven after cell transfer. 
This rapidly occurring effect is frequently seen in murine models of GvHD (Duran-Struuck et 
al., 2001; Albring et al.; 2010) and caused both by the activation of naïve T cells and the 
conditioning regimen which precedes cell transfer. For this reason, a similar but less 
pronounced effect could also be observed in control mice which received T cell depleted BM 
only. Following a short recovery phase, disease severity began to rise vigorously due to the 
activity of fully differentiated effector T cells which caused extensive tissue damage 
eventually leading to death of the animals. Importantly, this phase was completely absent in 
control mice demonstrating that it was solely caused by T cell activity. A difference between 
mice that received T cells from CD4Cre-transgenic or control mice could neither be observed 
during the early nor during the late phase of the disease course. In conclusion, results from 
aGvHD experiments suggest that Ptch does not affect the activation, differentiation or 
effector function of CTL or Th cells during a Th1-biased immune response in vivo. 
 
In another approach to study a potential effect of Ptch on T cells in vivo, I employed a 
transplantable murine melanoma model based on the B16F10 cell line. Subcutaneous 
inoculation of melanoma cells led to the development of primary tumours which allowed the 
evaluation of the CTL-mediated anti-tumour immune response on the one hand and tumour-
enhancing effects of Treg cells on the other hand. I found that without previous protective 
immunisation, tumours grew rapidly and could not be controlled by the immune system. 
DISCUSSION 
 90 
Following an anti-tumour immunisation, tumour control was much improved and 
approximately 30% of mice remained free of observable tumours during the experiments. 
Ablation of Ptch did not influence the ability to control tumour development under both 
conditions. Thus, that data obtained from tumour transplantation experiments was in line with 
the observations made during aGvHD experiments and showed that functional Ptch was also 
dispensable for the function of CTLs and Treg cells during an anti-tumour immune response in 
vivo. 
 
In summary, three different in vivo models have been employed to investigate general T cell 
features and proper functioning of several T cell subpopulations in a physiologic 
environment. Under all conditions, T cells from CD4Cre+/- Ptchflox/flox mice were highly 
comparable to cells derived from Ptchflox/flox control mice. Supported by the observations from 
in vitro experiments, the data convincingly demonstrates that T cell intrinsic expression of the 
Hh receptor Ptch is dispensable for proper T cell function in adaptive immune responses. 
 
4.4 Absence of Ptch in T cells does not lead to the activation of canonical Hh 
signalling 
In previous studies that focussed on the characterization of CD4Cre+/- Ptchflox/flox mice, it was 
reported that Cre-mediated recombination at the Ptchflox locus was almost complete in 
thymocytes which led to the predominant expression of the incomplete Ptchdel allele 
(Uhmann et al., 2011). However, this did not lead to the activation of canonical Hh signalling 
which was demonstrated by unaltered expression of the indicative transcription factors Gli1 
and Gli2. During expression analysis of peripheral T cells I was able to make similar 
observations. Although the reduction in wt Ptch expression was even more pronounced as 
compared to thymocytes and accompanied by expression of the Ptchdel allele, Gli 
transcription factor levels remained unaltered in CD4Cre+/- Ptchflox/flox mice. This 
demonstrated that the inability to activate canonical Hh signalling by Ptch ablation in T cells 
was not restricted to the thymus but also holds true for cells in the periphery. Although these 
observations were in line with the findings of Uhmann et al., they were still contrary to the 
consensus view that inactivation of Ptch should lead to active Hh signalling due to the 
discontinuation of its inhibitory effect on Smo. One possible explanation for this discrepancy 
could be the activity of a compensatory mechanism that takes effect after functional Ptch is 
lost. A possible candidate in this context might have been the Ptch homolog Ptch2. It has 
been shown that Ptch2 can bind Hh proteins with similar affinity to Ptch1, although it fails to 
compensate for the lack of Ptch1 in distinct cell types (Carpenter et al., 1998; Zaphiropoulos 
et al., 1999; Stone et al., 1996). Considering it possible that it may fulfil a compensatory role 
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in T cells, I analysed the expression of Ptch2 but was unable to detect transcripts in T cells at 
all whereas it was clearly detectable in mouse embryo samples. Considering the sensitivity of 
a PCR-based approach, the presence of Ptch2 in T cells and therefore a potential effect can 
be excluded. Yet it is conceivable that that other compensatory mechanisms may exist which 
prevent pathway activation in T cells despite the lack of functional Ptch. A synergistic 
function of other signalling pathways may also contribute to the masking of a phenotype in 
our model. Indeed, it has been shown that developmental signalling pathways such as Notch 
and Wnt are capable of interacting with Hh signalling (Yang and Niswander, 1995; Hallahan 
et al., 2004). It is possible that they play overlapping roles in thymopoiesis and may thus 
partially or totally compensate for any deficiencies in Hh signalling. 
 
A likely explanation for the lack of canonical Hh signalling in T cells despite Ptch ablation 
comes from the morphological characteristics of this cell type. Regarding the importance of 
the primary cilium for Hh signalling not only as a site of action but also as a integral 
component (Cheung et al., 2009; Endoh-Yamagami et al., 2009; Liem et al., 2009), the lack 
of pathway activation in this model could be explained by the absence of this organelle in 
cells of the haematopoietic lineage including T cells (Pazour and Witman 2003). It is 
conceivable that due to the lack of this compartment, proper interaction between Ptch and 
Smo or Smo and the Gli transcription factors cannot take place anymore which renders the 
cells incapable of responding to Hh ligands. In this scenario, gain- or loss-of-function 
mutations in upstream signalling components would not lead to the activation of Gli 
transcription factors and thus not affect cell function. This hypothesis is supported by findings 
of different groups in addition to our own. Gao and colleagues reported that the conditional 
inactivation of Smo did not influence development or function of HSCs or lymphocytes (Gao 
et al., 2009). Furthermore, the authors reported that they were unable to detect active Hh 
signalling in wild type HSCs or myeloid progenitor cells in the presence of Hh ligands despite 
the fact that the receptor Ptch and Smo were expressed. Alternative approaches which 
employed mouse models carrying a Gli1 deficiency or a gain-of-function mutation in Smo 
also failed to show any effect on the development of HSCs or lymphocytes. A different group 
which used the same conditional Smo knockout model confirmed these findings and 
additionally showed that continuous in vivo application of a Hh antagonist did not affect 
peripheral blood composition (Hofmann et al., 2009). Other studies conducted by Siggins et 
al. also supported this notion by demonstrating that intrinsic Ptch expression is not required 
for the development of different haematopoietic cells and does not lead to activation of Hh 
signalling either (Siggins et al., 2009). Further support for this hypothesis comes from 
observations which were made in our cooperating laboratories. It was found that specific 
inactivation of Ptch in myeloid cells (Pelczar et al., 2012) or B cells (unpublished 
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observations by Kai Dittmann, Department of Cellular and Molecular Immunology, University 
Medical Centre Göttingen, Germany) did neither cause activation of canonical Hh signalling 
nor affect normal development or function of cells either. Importantly, all these observations 
were made exclusively for cells of the haematopoietic lineage including HSCs while Hh 
signalling is clearly implicated in the homeostasis and differentiation of neural stem cells (Lai 
et al., 2003; Cai et al., 2008), intestinal stem cells (Ramalho-Santos et al., 2000), mammary 
stem cells (Liu et al., 2006) as well as embryonic stem cells (Kiprilov et al., 2008). Taken 
together, these data suggest that independency of intrinsic Hh signalling is a characteristic 
feature of the haematopoietic lineage starting from HSCs. Since this coincides with the 
absence of primary cilia which are appreciated as cellular signalling centres, it is thus 
conceivable that the inability to transduce Hh signals is caused by the lack of this cellular 
compartment. 
 
4.5 Investigations on the role of Hh signalling in the development and 
function of T cells 
Different studies have been conducted to elucidate the role of Hh signalling in lymphocyte 
function and development. Initial investigations were performed using FTOC to analyse fetal 
thymocyte development under physiologic conditions. It was reported that the application of 
rShh led to a block of thymocyte development at the DN stage while Hh antagonists 
prevented the transition from DP to SP stage (Outram et al., 2000). Later research found that 
the transcription factors Gli1 and Gli2 were required for the proper development of 
thymocytes (Drakopoulou et al., 2010). Although I suggest that T cells themselves are not 
capable of responding to Hh ligands, these observations may be explained by an indirect 
effect mediated through accessory cells present in the thymus. Moreover, it is important to 
note that fetal haematopoiesis is considerably different from adult haematopoiesis (Mold et 
al., 2010). It is thus conceivable that fetal and adult thymopoiesis may also have unique and 
distinct Hh signalling requirements.  
 
Further in vitro approaches focussed on the effect of recombinant Hh ligands or Hh 
antagonists on isolated peripheral T cells from wild type mice or humans. It was found that 
treatment with recombinant Hh ligands led to hyperactivation of T cells which was 
characterised by increased proliferation, cytokine production and the upregulation of 
activation markers (Stewart et al., 2002; Lowrey et al., 2002, Chan et al., 2006). Application 
of Hh antagonists had opposing effects and negatively affected T cell activation. Since these 
findings were based on the unspecific treatment of partially purified T cell populations, they 
can also be explained by an indirect effect through another cell type present in the culture. In 
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fact, this is supported by the finding that treatment of T cells with rShh, despite affecting cell 
proliferation, did not lead to activation of canonical Hh signalling in these cells (Chan et al., 
2006). However it is also conceivable that Hh ligands executed a stimulatory effect on T cells 
through non-canonical mechanisms. Nevertheless, due to the artificial nature of in vitro 
experiments these results may not necessarily reflect the physiological function of Hh 
signalling in T cells. 
 
More sophisticated analyses on the role of Hh signalling in T cells were performed using 
transgenic mouse models that overexpressed either the transcriptional activator or repressor 
form of Gli2 to study the effect of constitutive activation or repression of Hh signalling, 
respectively (Rowbotham et al. 2007, Rowbotham et al.,2008 Rowbotham et al. 2009, 
Furmanski et al., 2012). It was reported that overexpression of the transcriptional activator 
led to the activation of canonical Hh signalling which caused an attenuation in TCR signalling 
strength. This had negative implications for thymocyte development, homeostasis of 
peripheral T cells and mature T cell function. The opposite effects could be observed when 
the transcriptional repressor was overexpressed instead. Despite the fact that these models 
gave consisting results, the biologic relevance of the findings needs to be carefully 
evaluated. Due to the model design, activation or repression of Hh signalling occurs 
independent of upstream signalling components. If, according to my hypothesis, the signal 
initiation under normal conditions was blocked at the level of the surface receptors, then data 
from these models would not reflect the physiologic function of Hh signalling in T cells. 
However, it is important to note that transcriptional repression of Hh signalling should not 
effect T cell development or function in this scenario. The fact that repression of Hh signalling 
nevertheless affected T cell function is not consistent with my hypothesis so far. Yet another 
constituent of the experimental design may offer an explanation for this discrepancy. To 
ensure lymphocyte specificity expression, the modified transcription factors were placed 
under the control of an Lck promoter which is active in early thymocytes of both fetal and 
adult thymi (Aono et al., 2000). Especially during fetal thymopoiesis, other developmental 
pathways such as Notch or Wnt are active which might interact with Hh signalling at the level 
of transcriptional regulators. Suppression of this interaction by overexpression of a 
transcriptional repressor may therefore explain the discrepancy between these observations 
and my proposed model.  
 
Other groups focussed their investigations on the transmembrane protein Smo which is an 
upstream component of the Hh signalling machinery and an interaction partner of Ptch. El 
Andaloussi and colleagues showed that a shutdown of Smo after pre-TCR expression did not 
affect T cell development or function at all (El Andaloussi et al., 2006). On the other hand, 
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they reported that early ablation of Smo in an Mx1-based inducible system negatively 
impacted T cell development causing thymic atrophy and a significant loss in peripheral T 
cell numbers. They thus speculated that Hh signalling was only implicated in early thymocyte 
development. Using the same experimental approach however, two different studies 
obtained contrary results and showed that inducible shutdown of Smo did not affect 
haematopoiesis at all (Gao et al., 2009, Hofmann et al., 2009). These observations are in line 
with my own findings as they argue against a role of physiologic Hh signalling in the 
development of T cells. Furthermore, they support the notion that primary cilia are required 
for Hh signal transduction since they provide additional evidence that inactivation of 
upstream signalling component does not lead to the activation of canonical Hh signalling in 
T cells.  
 
Further insights into the role of Hh signalling in T cell development came from studies that 
focussed on the Hh receptor Ptch itself. Uhmann and colleagues reported that inducible Ptch 
ablation prevented lymphocyte development already at the level of CLP in the BM (Uhmann 
et al., 2007). Furthermore, they demonstrated that lymphocyte-intrinsic Ptch expression was 
dispensable for their development and suggested that its expression was required in the 
stromal cell compartment instead. In a subsequent study, they further excluded that Ptch 
expression in the thymic stroma was required and suggested that its expression might be 
relevant in prethymic stromal cells (Uhmann et al., 2011). This hypothesis was supported by 
the work of another group which reported that specific inactivation of Ptch in the 
haematopoietic system failed to affect T cell development or function (Siggins et al., 2009). 
Instead, they proposed a model in which Ptch expression was required in epithelial cells for 
proper lymphocyte development. These findings are of central importance for the 
understanding of Hh signalling in T cells as they help to reconcile much of the previously 
contradictory data. Several groups which performed studies in this field employed models in 
which the manipulation of Hh signalling components was not restricted to haematopoietic 
cells although they were in the focus of the study. Since it is difficult if not impossible to 
differentiate between cell-intrinsic and -extrinsic effects of Hh signalling in these models, it 
can be misleading to draw conclusions out of these experiments. Indeed, the majority of 
observations which are inconsistent with the model proposed in this study could be explained 
by indirect effects on T cells which were mediated by non-haematopoietic cells. 
 
Taken together, various studies have been performed to investigate the role of Hh signalling 
in haematopoiesis. The choice of different experimental approaches, the spatially and 
temporally complex regulation of this developmental pathway and functional redundancy of 
its components have yielded different and partially contrary results. Based on the study of the 
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CD4Cre+/- Ptchflox/flox mouse model, my data is not in favour of a role for Hh signalling in adult 
T cell development after the DP stage of thymopoiesis. In addition, my study demonstrates 
that inactivation of Ptch does not affect the function of mature T cell both in vitro and in vivo. 
Ablation of Ptch in this model also did not lead to the activation of canonical Hh signalling 
which is supposedly caused by the lack of primary cilia on haematopoietic cells. There is also 
no indication for non-canonical signalling activity which might affect cellular behaviour by 
circumventing the Smo-Gli axis. Thus I propose a model in which Ptch-mediated intrinsic Hh 
signalling is dispensable for intermediate and late T cell development as well as for the 
function of mature T cells. This model is supported by several reports from different groups 
and can be reconciled with the majority of other observations. In conclusion, my data 
provides new insights into the role of Hh signalling in T cells and might help to gain a better 





The hedgehog signalling pathway is a highly conserved key regulator of animal development 
and required for homeostasis of adult tissues both in invertebrates and vertebrates. In 
addition, a large number of studies have suggested that this pathway is also implicated in 
different aspects of vertebrate haematopoiesis and lymphopoiesis. Its precise role in this 
context however appears to be complex and conflicting data reported from different groups 
have prevented a comprehensive understanding of its implication. The aim of the study at 
hand was to further improve the understanding of Hh signalling and its involvement in the 
development and function of T cells which are a central component of the adaptive immune 
system. For this purpose, a mouse model was employed in which expression of the Hh 
receptor Ptch was ablated specifically in T cells. Since Ptch is known to be a negative 
regulator of Hh signalling, its inactivation was expected to activate the canonical Hh 
signalling pathway and thus affect T cell behaviour. However, it was found that Ptch ablation 
only marginally affected the development of thymocytes at the transition from the DP to the 
SP stage. This minor effect did not have any implications for the total number of peripheral 
T cells or for the composition of the T cell pool. Furthermore, the activation state of peripheral 
T cells was found to be unaltered upon Ptch ablation indicating that functional characteristics 
were not affected either. Indeed, different experimental approaches in vitro which focused on 
several key characteristics of mature T cell populations failed to reveal any impact of the 
Ptch inactivation. Similar results were obtained from analyses of Ptch-deficient T cells in 
several disease models in vivo thus confirming that T cell-intrinsic Ptch expression is 
dispensable for proper T cell function even under physiological conditions. Interestingly and 
contrary to the consensus view, it was found that Ptch ablation did not result in the activation 
of the canonical Hh signalling cascade. Although this discrepancy can be explained in 
several ways, it is most likely accounted for by the lack of primary cilia on T cells which have 
emerged as important initiation sites of different signalling pathways. This hypothesis is 
supported by several independent reports which demonstrated that ablation of another 
upstream pathway component in cells of the haematopoietic lineage did not cause pathway 
activation or affect development or function of these cells either. Taken together, this thesis 
presents comprehensive evidence that intrinsic expression of the Hh receptor Ptch is 
dispensable for intermediate and late T cell development as well as for T cell function both in 
vitro and in vivo. In addition, it suggests that intrinsic canonical Hh signalling in T cells is not 
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7.1 List of abbreviations 
Abbreviation Full name 
7-AAD 7-Aminoactinomycin D 
aGvHD Acute Graft-versus-Host disease 
APC Antigen presenting cell 
BALF Bronchoalveolar lavage fluid 
BCC Basal cell carcinoma 
BM Bone marrow 
BMDM Bone marrow derived macrophage 
BOC Brother of CDO 
bp Base pair 
BSA Bovine serum albumin 
BTLA B- and T-lymphocyte attenuator 
-TrCP beta-transducin repeat containing protein 
cAMP 3′,5′-cyclic adenosine monophosphate 
CD Cluster of differentiation 
cDNA Complementary DNA 
CDO Cell adhesion molecule down-regulated by oncogenes 
CFA Complete Freund’s adjuvant 
cGvHD Chronic Graft-versus-Host disease 
Ck1  Casein kinase 1 alpha 
CLP Common lymphoid progenitor 
CLR C-type lectin receptor 
ConA Concanavalin A 
cpm Counts per minute 
cTEC Cortical thymic epithelial cells 
CTL Cytotoxic T lymphocyte 
CTLA-4 Cytotoxic T lymphocyte antigen 4 
Dex Dexamethasone 





DMEM Dulbecco's modified eagle medium 
DN Double negative 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide Triphosphate 
DP Double positive 
EDTA Ethylenediaminetetraacetic acid 
EGFR Epidermal growth factor receptor 
ELISA Enzyme-linked immunosorbent assay 
ER Endoplasmic reticulum 
ETP Early thymocyte progenitor 
FACS Fluorescence-activated cell sorting 
FBS Fetal bovine serum 
FGF Fibroblast growth factor 
FITC Fluorescein isothiocyanate 
Fn Fibronectin 
FoxP3 Forkhead box P3 
FSC Forward scatter of light 
FTOC Fetal thymic organ culture 
GAS1 Growth arrest-specific gene 1 
GATA3 GATA binding protein 3 
GEF Guanine nucleotide exchange factor 
Gi Inhibitory G protein 
GITR 
glucocorticoid induced tumour necrosis factor receptor 
family related gene 
Gli glioma-associated oncogene 
Gli-A Activator form of Gli 
Gli-FL Full-length form of Gli 
Gli-R Repressor form of Gli 
GM-CSF Granulocyte macrophage colony-stimulating factor 
GPCR G protein-coupled receptor 
GRK2 G protein-coupled receptor kinase 2 
GSK-3  Glycogen synthase kinase 3 beta 
GvHD Graft-versus-Host disease 
Hh Hedgehog 
Hhat Hedgehog acetyltransferase 
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HIP Hedgehog interacting protein 
HPRT1 Hypoxanthine-guanine phosphoribosyltransferase one 
HRP Horseradish peroxidase 




IVC individually ventilated cage 
ICOS Inducible T cell co-stimulator 
IFN Interferon 
Ihh Indian hedgehog 
IL Interleukin 
iTreg Induced regulatory T cell 
JAK Janus kinase 
LCCM L cell conditioned medium 
mAb Monoclonal antibody 
MACS Magnetic activated cell sorting 
MB Medulloblastoma 
MFI Mean fluorescent intensity 
MHC Major histocompatibility complex 
MLR Mixed leukocyte reaction 
MPP Multipotent progenitor 
mTEC medullary thymic epithelial cells 
nTreg Naturally occurring regulatory T cell 
OD Optical density 
Ova Ovalbumin 
PAMP Pathogen-associated molecular pattern 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PD-1 Programmed cell death 1 
PE Phycoerythrin 
PI3K Phosphatidylinositide 3-kinase 
PI4P Phosphatidylinositol-4-phosphate 
PKA Protein kinase A 
PLC-  Phospholipase C gamma 
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PRR Pattern recognition receptor 
PS Penicillin / Streptomycin 
Ptch Patched1 
qRT-PCR 
Quantitative reverse transcription polymerase chain 
reaction 
RMS Rhabdomyosarcoma 
RNA Ribonucleic acid 
RND Resistance-nodulation-division 
rShh Recombinant sonic hedgehog 
SDS Sodium dodecyl sulphate 
SEM Standard error of the mean 
Shh Sonic hedgehog 
Smo Smoothened 
SP Single positive 
SPF Specific pathogen free 
SSC Side scatter of light 
SSD Sterol-sensing domain 
STAT Signal transducer and activator of transcription 
Sufu Suppressor of fused 
TAC Tris ammonium chloride 
Taq Thermus aquaticus 
T-bet T-box expressed in T cells 
TCR T cell receptor 
TE Tris EDTA 
TGF-  Transforming growth factor beta 
Th T helper cell 
Tiam-1 T-lymphoma invasion and metastasis 1 
TLR Toll-like receptor 
TNFR Tumour necrosis factor receptor 
TNF-  Tumour necrosis factor alpha 
Treg Regulatory T cell 
VCAM-1 Vascular cell adhesion molecule-1 
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